<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65758</article-id><article-id pub-id-type="doi">10.7554/eLife.65758</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Insulin-producing β-cells regenerate ectopically from a mesodermal origin under the perturbation of hemato-endothelial specification</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-218761"><name><surname>Liu</surname><given-names>Ka-Cheuk</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6082-8801</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219189"><name><surname>Villasenor</surname><given-names>Alethia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87787"><name><surname>Bertuzzi</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219191"><name><surname>Schmitner</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219192"><name><surname>Radros</surname><given-names>Niki</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219193"><name><surname>Rautio</surname><given-names>Linn</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225444"><name><surname>Mattonet</surname><given-names>Kenny</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9705-8086</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212423"><name><surname>Matsuoka</surname><given-names>Ryota L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6214-2889</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225443"><name><surname>Reischauer</surname><given-names>Sven</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6955-9481</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-7189"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0382-0026</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-22244"><name><surname>Andersson</surname><given-names>Olov</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6715-781X</contrib-id><email>Olov.Andersson@ki.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Cell and Molecular Biology, Karolinska Institutet</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff2"><label>2</label><institution>Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>Department of Neuroscience, Karolinska Institutet</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff4"><label>4</label><institution>Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff5"><label>5</label><institution>Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Cardio-Pulmonary Institute, Frankfurt, Germany; Medical Clinic I, (Cardiology/Angiology) and Campus Kerckhoff, Justus-Liebig-University Giessen</institution><addr-line><named-content content-type="city">Giessen</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ober</surname><given-names>Elke</given-names></name><role>Reviewing Editor</role><aff><institution>University of Copenhagen</institution><country>Denmark</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>08</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65758</elocation-id><history><date date-type="received" iso-8601-date="2020-12-15"><day>15</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-08-06"><day>06</day><month>08</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-02-02"><day>02</day><month>02</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.02.01.429189"/></event></pub-history><permissions><copyright-statement>© 2021, Liu et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Liu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65758-v1.pdf"/><abstract><p>To investigate the role of the vasculature in pancreatic β-cell regeneration, we crossed a zebrafish β-cell ablation model into the avascular <italic>npas4l</italic> mutant (i.e. <italic>cloche</italic>). Surprisingly, β-cell regeneration increased markedly in <italic>npas4l</italic> mutants owing to the ectopic differentiation of β-cells in the mesenchyme, a phenotype not previously reported in any models. The ectopic β-cells expressed endocrine markers of pancreatic β-cells, and also responded to glucose with increased calcium influx. Through lineage tracing, we determined that the vast majority of these ectopic β-cells has a mesodermal origin. Notably, ectopic β-cells were found in <italic>npas4l</italic> mutants as well as following knockdown of the endothelial/myeloid determinant Etsrp. Together, these data indicate that under the perturbation of endothelial/myeloid specification, mesodermal cells possess a remarkable plasticity enabling them to form β-cells, which are normally endodermal in origin. Understanding the restriction of this differentiation plasticity will help exploit an alternative source for β-cell regeneration.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>differentiation</kwd><kwd>beta-cell regeneration</kwd><kwd>ectopic beta-cells</kwd><kwd>cellular origin</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Ragnar Söderbergs stiftelse</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Andersson</surname><given-names>Olov</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max Planck Society</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Andersson</surname><given-names>Olov</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Andersson</surname><given-names>Olov</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Karolinska Institutetvia SRP Diabetes &amp; StratRegen</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Andersson</surname><given-names>Olov</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>772365</award-id><principal-award-recipient><name><surname>Andersson</surname><given-names>Olov</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetic analyses revealed the remarkable plasticity of mesodermal cells to differentiate across the germ layers to form insulin-producing β-cells, which are normally of endodermal origin.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The concept of embryonic development and cell fate determination was illustrated by the famous Waddington landscape model decades ago (<xref ref-type="bibr" rid="bib48">Waddington, 1957</xref>). Waddington’s model not only shows the importance of spatiotemporal precision in cell differentiation but also metaphorises cell fate determination as a sequential and irreversible event. In this hierarchical model, the endoderm follows the lineage paths downwards and progressively differentiates into multiple endodermal cell types, including pancreatic β-cells. Likewise, the mesoderm stays in the mesodermal lineage paths and differentiates into endothelial cells and other mesodermal cell types. However, in recent decades, multiple studies have suggested that committed cells are capable of differentiating across the germ layer boundaries by converting embryonic and/or adult mesodermal fibroblasts into ectodermal neuronal cells (<xref ref-type="bibr" rid="bib47">Vierbuchen et al., 2010</xref>), multipotent neural stem cells (<xref ref-type="bibr" rid="bib32">Ring et al., 2012</xref>), endodermal hepatocyte-like cells (<xref ref-type="bibr" rid="bib16">Huang et al., 2011</xref>; <xref ref-type="bibr" rid="bib37">Sekiya and Suzuki, 2011</xref>), or pancreatic β-like cells (<xref ref-type="bibr" rid="bib51">Zhu et al., 2016</xref>) in vitro. These studies highlight the feasibility of converting mesodermal cells into ectodermal or endodermal cells in vitro.</p><p>Despite the extensive studies on cell fate conversion across germ layers in vitro, the number of in vivo studies is limited. Ectopic expression of <italic>Xsox17β</italic> in <italic>Xenopus</italic> embryos relocated cells normally fated to become ectoderm to appear in the gut epithelium, suggesting a possible change in cell fate in vivo (<xref ref-type="bibr" rid="bib5">Clements and Woodland, 2000</xref>). Similarly, ectopic expression of <italic>sox32</italic>/<italic>casanova</italic> in presumptive endothelial cells switched their cell fate to endoderm in zebrafish embryos (<xref ref-type="bibr" rid="bib19">Kikuchi et al., 2001</xref>). Furthermore, aggregated morulae and chimeric mouse embryos of β-catenin mutants provided evidence of precardiac mesoderm formation in endodermal tissues in vivo (<xref ref-type="bibr" rid="bib22">Lickert et al., 2002</xref>). These studies suggest that the classical in vivo germ layer boundaries may not be as clear-cut as previously thought.</p><p>In this study, we aimed to elucidate the importance of the vasculature in pancreatic β-cell regeneration, which plays a crucial role in potential therapeutic strategies against diabetes. We employed <italic>cloche</italic> zebrafish mutants as an avascular model. The mutation of <italic>npas4l</italic>, a master regulator of endothelial and hematopoietic cell fates, is responsible for the severe loss of most endothelial and blood cells in <italic>cloche</italic> mutants (<xref ref-type="bibr" rid="bib30">Parker and Stainier, 1999</xref>; <xref ref-type="bibr" rid="bib31">Reischauer et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Stainier et al., 1995</xref>). Unexpectedly, the <italic>npas4l</italic> mutation induced ectopic β-cell formation in the mesenchymal region outside of the pancreas after β-cell ablation. Lineage-tracing mesodermal cells expressing <italic>draculin</italic> (<italic>drl</italic>), <italic>npas4l</italic>, and <italic>etsrp</italic> (previously named <italic>etv2</italic>) validated the mesodermal lineage of the ectopic β-cells, which are normally endodermal in origin. These findings offer novel insights into cell fate determination and an alternative source of β-cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Ectopic β-cell formation in <italic>npas4l</italic> mutants</title><p>To determine the importance of vasculogenesis and vascularisation for β-cell regeneration, we examined β-cell formation in zebrafish carrying the <italic>cloche</italic> mutation (<italic>npas4l<sup>s5</sup></italic> mutation) after β-cell ablation, i.e., in the <italic>Tg(ins:Flag-NTR);Tg(ins:H2BGFP;ins:DsRed)</italic> model. Nitroreductase (NTR), expressed under the <italic>insulin</italic> promoter, converts the prodrug metronidazole (MTZ) to a cytotoxin to specifically ablate insulin-producing β-cells (<xref ref-type="bibr" rid="bib6">Curado et al., 2007</xref>). The homozygous mutation of <italic>npas4l</italic> significantly increased the number of <italic>ins</italic>:H2BGFP-positive cells during the β-cell regeneration period (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). In addition, we observed a distinctive ectopic β-cell population in the mesenchymal region outside of the pancreas in the <italic>npas4l<sup>−/−</sup></italic> group, an ectopic location that was very rarely observed in the sibling controls (including both wild-type and heterozygous siblings). This ectopic population of β-cells contributed to the major increase in the number of <italic>ins</italic>:H2BGFP-positive cells during β-cell regeneration (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Moreover, the comparable and sparse numbers of <italic>ins</italic>:DsRed-positive cells in the controls and mutants indicate that the <italic>npas4l</italic> mutation did not enhance the survival of β-cells during the ablation (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>) because the extended maturation time of DsRed (<xref ref-type="bibr" rid="bib3">Baird et al., 2000</xref>) restricted the detection of DsRed to any surviving β-cells.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Ectopic β-cell formation in <italic>npas4l</italic> mutants.</title><p>(<bold>A, B</bold>) Representative confocal projections of the pancreas and neighbouring tissues of control siblings and <italic>npas4l<sup>−/−</sup> Tg(ins:Flag-NTR);Tg(ins:H2BGFP;ins:DsRed)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ at 1–2 dpf, displaying regenerated β-cells in green and older β-cells that likely survived the ablation in yellow overlap as the DsRed fluorescence driven by the insulin promoter remained in these cells, at the same time as DsRed had not had enough time to mature in the regenerated β-cells (arrowheads). The ectopic β-cells are indicated by white dashed rectangle. Pancreata are outlined by solid white lines. (<bold>C</bold>) Quantification of the pancreatic or ectopic β-cells per larva at 3 dpf. ****p&lt;0.0001 (Šidák’s multiple comparisons test); n = 24 (control) and 19 (<italic>npas4l<sup>−/−</sup></italic>). Quantification data are represented as the mean ± SEM. (<bold>D, E</bold>) Representative image projections of the pancreas and neighbouring tissues in control siblings and <italic>npas4l</italic><sup>-/-</sup> <italic>Tg(ins:Flag-NTR);Tg(ptf1a:EGFP)</italic> larvae at 3 dpf after β-cell ablation by MTZ at 1–2 dpf, displaying β-cells in red with immunostaining for insulin and <italic>ptf1a:</italic>EGFP<sup>+</sup> exocrine pancreas in green. Pancreata are outlined by solid white lines. Dashed line outlines ectopic β-cells in the mesenchyme (<bold>E</bold>). (<bold>F–K</bold>) Representative images and projections of the pancreas and neighbouring mesenchyme of control siblings and <italic>npas4l</italic><sup>-/-</sup> <italic>Tg(ins:Flag-NTR);Tg(hand2:EGFP)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ at 1–2 dpf, displaying β-cells in red with immunostaining for insulin and <italic>hand2:</italic>EGFP<sup>+</sup> mesenchyme in green. White arrowheads point to β-cells in the pancreas (<bold>F, I</bold>). Dashed rectangles indicate the ectopic β-cells intermingling with the mesenchyme between the pronephros and the pancreas, without co-expressing insulin and <italic>hand2:</italic>EGFP (<bold>J, K</bold>). Selected area in dashed ovals shows other ectopic β-cells intermingling with the mesenchyme ventral to the pancreas (<bold>I, K</bold>). Scale bars = 20 μm. Anatomical axes: D (dorsal), V (ventral), A (anterior), and P (posterior).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Mutation of <italic>npas4l</italic> suppresses the development of exocrine pancreas.</title><p>(<bold>A, B</bold>) Representative image projections of the pancreas in control siblings and <italic>npas4l<sup>−/−</sup> Tg(ptf1a:EGFP)</italic> larvae, without carrying the <italic>ins:Flag-NTR</italic> transgene, that is during regular development. These larvae were controls for the β-cell ablation, that is still treated with MTZ from 1 to 2 dpf (not leading to β-cell ablation due to the absence of <italic>ins:Flag-NTR</italic>). Insulin-expressing β-cells are displayed in red with immunostaining for insulin and <italic>ptf1a:</italic>EGFP<sup>+</sup> exocrine pancreas in green. Pancreata are outlined by solid white lines. Scale bars = 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig1-figsupp1-v1.tif"/></fig></fig-group><p>To visualise the location of the ectopic β-cells better, we labelled the pancreas with <italic>ptf1a:</italic>EGFP expression and observed not only a drastic reduction in the pancreas size (<xref ref-type="fig" rid="fig1">Figure 1D,E</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) but also the regeneration of β-cells clearly outside of the <italic>ptf1a</italic>-expressing exocrine pancreas in <italic>npas4l</italic> mutants (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). By labelling the mesenchyme with <italic>hand2:</italic>EGFP expression (<xref ref-type="fig" rid="fig1">Figure 1F–K</xref>), we further revealed that the majority of the ectopic β-cells formed in <italic>npas4l</italic> mutants intermingled with <italic>hand2:</italic>EGFP-positive mesenchymal cells between the pronephros and the pancreas (<xref ref-type="fig" rid="fig1">Figure 1J,K</xref>). In addition, we occasionally observed ectopic β-cells intermingled with <italic>hand2:</italic>EGFP-positive mesenchymal cells ventral to the pancreas (<xref ref-type="fig" rid="fig1">Figure 1I,K</xref>). Although the ectopic β-cells were located among the mesenchymal cells, they did not express <italic>hand2:</italic>EGFP.</p></sec><sec id="s2-2"><title>The ectopic β-cells co-express insulin and endocrine markers in <italic>npas4l</italic> mutants</title><p>Next, we examined multiple pancreatic endocrine and β-cell markers, including Isl1, <italic>neurod1</italic>, <italic>pdx1</italic>, <italic>mnx1</italic>, <italic>pcsk1</italic>, and <italic>ascl1b</italic> (the functional homologue to <italic>Neurog3</italic> in mammals), to validate the β-cell identity of the ectopic insulin-producing cells. The majority of the ectopic β-cells co-expressed insulin as well as these markers during β-cell regeneration (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The high co-expression of <italic>pcsk1</italic> (<xref ref-type="fig" rid="fig2">Figure 2R,S</xref>, <xref ref-type="table" rid="table1">Table 1</xref>), which encodes an enzyme necessary for insulin biosynthesis, indicates that most of the β-cells in the ectopic population are likely functional. Consistent with previous findings in pancreatic β-cells, not all ectopic β-cells expressed <italic>ascl1b:</italic>EGFP (<xref ref-type="fig" rid="fig2">Figure 2V,W</xref>, <xref ref-type="table" rid="table1">Table 1</xref>), which suggests that <italic>ascl1b</italic> works as a transient endocrine cell fate regulator (<xref ref-type="bibr" rid="bib9">Flasse et al., 2013</xref>). In contrast with Isl1, <italic>mnx1, pcsk1</italic>, and <italic>ascl1b</italic>, we observed lower co-expression levels of <italic>neurod1</italic> and <italic>pdx1</italic> in ectopic β-cells compared with the pancreatic population in <italic>npas4l</italic> mutants (<xref ref-type="table" rid="table1">Table 1</xref>). In addition to the reduction in pancreas size (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), the <italic>pdx1</italic>-expressing pancreatic duct was also reduced in the <italic>npas4l</italic> mutant (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), indicating that the pancreas and its duct did not expand to form the ectopic β-cells. These observations together suggest that the pancreatic and ectopic β-cells are similar, yet they are two distinct β-cell populations.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The ectopic β-cells co-express insulin and endocrine markers in <italic>npas4l</italic> mutants.</title><p>Representative confocal images of the tissues adjacent to the pancreas of control siblings and <italic>npas4l<sup>−/−</sup> Tg(ins:Flag-NTR)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ at 1–2 dpf, displaying cells expressing pancreatic endocrine cell markers Isl1 (<bold>A–B’</bold>), <italic>neurod1</italic> (<bold>E–F’</bold>), <italic>pdx1</italic> (<bold>I–J’</bold>), <italic>mnx1</italic> (<bold>M–N’</bold>), <italic>pcsk1</italic> (<bold>Q–R’</bold>), and <italic>ascl1b</italic> (<bold>U–V’</bold>) in green, and ectopic β-cells in red with immunostaining for insulin (except <bold>Q–R’</bold> with the mCherry fluorescence driven by the insulin promoter). Arrowheads point to ectopic β-cells that express corresponding markers. Arrows point to β-cells that do not express <italic>ascl1b</italic> (<bold>V and V’</bold>). <bold>B’</bold>, <bold>F’</bold>, <bold>J’</bold>, <bold>N’</bold>, <bold>R’</bold>, and <bold>V’</bold> are magnified from the areas indicated by the white dashed square in <bold>B</bold>, <bold>F</bold>, <bold>J</bold>, <bold>N</bold>, <bold>R</bold>, and <bold>V</bold>, respectively. Quantification of β-cells with or without corresponding marker expression in the ectopic location (<bold>C, G, K, O, S, and W</bold>) or in the pancreas (<bold>D, H, L, P, T, and X</bold>) per larva at 3 dpf. *p=0.0310, **p=0.0039, and ****p&lt;0.0001 (Šidák’s multiple comparisons test); (<bold>C, D</bold>) n = 30 (control) and 31 (<italic>npas4l<sup>−/−</sup></italic>); (<bold>G, H</bold>) n = 8 (control) and 8 (<italic>npas4l</italic><sup>−<italic>/−</italic></sup>); (<bold>K, L</bold>) n = 25 (control) and 24 (<italic>npas4l<sup>−/−</sup></italic>); (<bold>O, P</bold>) n = 21 (control) and 23 (<italic>npas4l<sup>−/−</sup></italic>); (<bold>S, T</bold>) n = 40 (control) and 32 (<italic>npas4l<sup>−/−</sup></italic>); (<bold>W and X</bold>) n = 13 (control) and 13 (<italic>npas4l<sup>−/−</sup></italic>). Data are represented as the mean ± SEM. Scale bars = 20 μm except <bold>B’</bold>, <bold>F’</bold>, <bold>J’</bold>, <bold>N’</bold>, <bold>R’</bold>, and <bold>V’</bold> (10 μm). Anatomical axes: D (dorsal), V (ventral), A (anterior), and P (posterior).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Mutation of <italic>npas4l</italic> inhibits <italic>pdx1</italic>-expressing pancreatic duct formation.</title><p>(<bold>A–D</bold>) Representative image projections of the pancreas and the surrounding tissues in control siblings and <italic>npas4l<sup>−/−</sup> Tg(pdx1:EGFP)</italic> zebrafish larvae without (<bold>A, B</bold>) or with (<bold>C, D</bold>) <italic>ins:Flag-NTR</italic> expression at 3 dpf after treatment with MTZ at 1–2 dpf. Hence (<bold>A</bold> and <bold>B</bold>) were β-cell ablation controls while the β-cells in (<bold>C</bold> and <bold>D</bold>) had been ablated. Insulin-expressing β-cells are displayed in red with immunostaining for insulin and <italic>pdx1</italic>-expressing cells (including pancreatic ductal cells and upper intestine) in green. The dashed rectangle indicates that the ectopic β-cells were distant from the <italic>pdx1</italic>-expressing pancreatic ducts. Scale bars = 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig2-figsupp1-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Percentages of pancreatic or ectopic cells co-expressing insulin and corresponding marker gene or protein in <italic>npas4l</italic> mutants.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center">Marker gene/protein</th><th align="center">Pancreatic co-expression (%)</th><th align="center">Ectopic co-expression (%)</th></tr></thead><tbody><tr><td align="center">Isl1</td><td align="center">97.9</td><td align="center">96.8</td></tr><tr><td align="center"><italic>neurod1</italic></td><td align="center">97.5</td><td align="center">17.5</td></tr><tr><td align="center"><italic>pdx1</italic></td><td align="center">72.1</td><td align="center">32.8</td></tr><tr><td align="center"><italic>mnx1</italic></td><td align="center">75.3</td><td align="center">70.2</td></tr><tr><td align="center"><italic>pcsk1</italic></td><td align="center">85.1</td><td align="center">74.1</td></tr><tr><td align="center"><italic>ascl1b</italic></td><td align="center">21.2</td><td align="center">17.8</td></tr></tbody></table></table-wrap></sec><sec id="s2-3"><title>Ectopic β-cells can respond to glucose by displaying calcium oscillations</title><p>We further assessed the functionality and maturity of the ectopic β-cells by examining the calcium ion oscillation in vivo to determine their ability in responding to glucose to secrete insulin in the <italic>Tg(ins:GCaMP6s);Tg(ins:mCherry);Tg(ins:Flag-NTR) npas4l</italic> zebrafish mutants. After β-cell ablation by MTZ and one day of β-cell regeneration, we found comparable proportions of pancreatic (66%) and ectopic (67%) β-cells displaying mild and basal levels of calcium activity at the baseline (<xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="video" rid="video1">Video 1</xref>). Upon glucose treatment, 50% of pancreatic β-cells and 33% of ectopic β-cells elicited calcium oscillations, suggesting that a portion of the pancreatic and ectopic β-cells have the ability to respond to glucose to secrete insulin in the <italic>npas4l</italic> mutants during β-cell regeneration.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Ectopic β-cells can respond to glucose by displaying calcium oscillations.</title><p>Representative images captured from a live calcium imaging video of <italic>npas4l</italic><sup><italic>−/−</italic></sup><italic>Tg(ins:GCaMP6s);Tg(ins:mCherry);Tg(ins:Flag-NTR)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ from 1 to 2 dpf, showing β-cells expressing <italic>ins:mCherry</italic> in red and displaying calcium activity in green in the pancreatic (<bold>A, B</bold>) or ectopic (<bold>C, D</bold>) domain at the baseline (<bold>A, C</bold>) or after the addition of 200 mM of glucose to the E3 medium (<bold>B, D</bold>). (<bold>E</bold>) Sequential images captured from a live calcium imaging video to show the oscillation of calcium signalling at the baseline and after the glucose treatment, displaying the GCaMP6s signal in green. (<bold>F</bold>) Quantification of pancreatic or ectopic β-cells displaying calcium activity at the baseline or after glucose treatment in 11 (pancreatic) or 17 (ectopic) <italic>npas4l</italic> zebrafish mutants. Scale bars = 10 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig3-v1.tif"/></fig><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-65758-video1.mp4"><label>Video 1.</label><caption><title>Live calcium imaging of β-cells in a <italic>npas4l</italic> mutant.</title><p>An example video of live calcium imaging of both pancreatic and ectopic β-cells in a <italic>Tg(ins:GCaMP6s);Tg(ins:mCherry);Tg(ins:Flag-NTR) npas4l</italic> mutant at 3 dpf after β-cell ablation from 1 to 2 dpf, displaying GCaMP6s signal in green. Glucose (200 mM) was added to the E3 media at around 9 min in the video.</p></caption></media></sec><sec id="s2-4"><title>The ectopic β-cells are of mesodermal origin in <italic>npas4l</italic> mutants and <italic>etsrp</italic> morphants</title><p>We have previously shown that <italic>npas4l</italic> expression is first initiated in the lateral plate mesoderm at the tailbud stage by in situ hybridisation (<xref ref-type="bibr" rid="bib31">Reischauer et al., 2016</xref>). In this study, we examined <italic>npas4l</italic> expression at 20 hr postfertilisation (hpf) and found that <italic>npas4l</italic> was severely reduced in the lateral plate mesoderm in the <italic>npas4l</italic> mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A,B</xref>), whereas normal expression levels were observed in the tailbud and brain. The cells with reduced <italic>npas4l</italic> expression were still present in the lateral plate mesoderm as demonstrated by the embryos incubated overnight to further develop the <italic>npas4l</italic> expression signal (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B’</xref>). On the contrary, there were no significant differences in the expression of the examined early mesodermal or endodermal transcription factors <italic>foxa2</italic>, <italic>gsc</italic>, and <italic>mixl1</italic>, or the pancreatic endocrine progenitor marker <italic>ascl1b</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C–J</xref>). Because the ectopic β-cells induced by the <italic>npas4l</italic> mutation also resided in the mesenchymal region, and <italic>npas4l</italic> can act cell-autonomously to affect the hematopoietic and endothelial lineages (<xref ref-type="bibr" rid="bib30">Parker and Stainier, 1999</xref>), we hypothesised that the ectopic β-cells originated from a mesodermal lineage.</p><p>To determine whether the mesoderm was the origin of the ectopic β-cells, we genetically traced the mesodermal cells using <italic>drl:CreER<sup>T2</sup></italic>, a tamoxifen-inducible Cre transgene driven by a <italic>drl</italic> promoter (<xref ref-type="bibr" rid="bib28">Mosimann et al., 2015</xref>). The spatial expression pattern of <italic>drl</italic> in the <italic>npas4l</italic> mutants resembled that in the sibling controls (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), suggesting that <italic>npas4l</italic> mutation did not induce any ectopic expression of <italic>drl</italic> to disrupt the lineage-tracing approach. In combination with a <italic>−3.5ubb:LOXP-EGFP-LOXP-mCherry</italic> (<italic>ubi:Switch</italic>) reporter (<xref ref-type="bibr" rid="bib27">Mosimann et al., 2011</xref>), the <italic>drl</italic>-expressing mesodermal cells were labelled in red in <italic>Tg(drl:CreER<sup>T2</sup>);Tg(ubi:Switch);Tg(ins:Flag-NTR)</italic> (<italic>drl</italic>-tracing) zebrafish larvae after 4-hydroxytamoxifen (4-OHT) induction (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). We treated the transgenic embryos with 4-OHT at 10–12 hpf. We chose to label the mesodermal cells during this period as neither endothelial/hematopoietic cells nor β-cells have developed at that stage, i.e., to exclude confounding effects of endothelial/hematopoietic cells or possible ectopic expression of the lineage tracer in the β-cells of the <italic>npas4l</italic> mutant. To ablate the β-cells, we incubated the 4-OHT-treated transgenic embryos in MTZ at 1–2 days postfertilisation (dpf). We allowed the β-cells to regenerate for 30 hr before we fixed the larvae at 3 dpf for immunostaining (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The ectopic β-cells are of mesodermal origin in <italic>npas4l</italic> mutants and <italic>etsrp</italic> morphants.</title><p>(<bold>A</bold>) Constructs of <italic>−6.35drl:Cre-ER<sup>T2</sup></italic> (<italic>drl:CreER<sup>T2</sup></italic>) and <italic>−3.5ubb:LOXP-EGFP-LOXP-mCherry</italic> (<italic>ubi:Switch</italic>). Upon 4-OHT induction between 10 and 12 hpf, Cre recombinase expressed by the <italic>drl</italic> promoter cleave the <italic>loxP</italic> sites to allow <italic>ubb:mCherry</italic> expression in the cells that once expressed <italic>drl</italic>. (<bold>B</bold>) Scheme for tracing the mesodermal lineage of ectopic β-cells in control siblings and <italic>npas4l</italic><sup>−/−</sup> <italic>Tg(ins:Flag-NTR);Tg(ubi:Switch);Tg(drl:CreER<sup>T2</sup>)</italic> zebrafish larvae. (<bold>C, D, I, and J</bold>) Quantification of the pancreatic or ectopic β-cells with or without mesodermal lineage in <italic>npas4l</italic> mutants (<bold>C, D</bold>) or <italic>etsrp</italic> morpholino (MO)-injected larvae (<bold>I, J</bold>) at 3 dpf. *p=0.0227 and ****p&lt;0.0001 (Šidák’s multiple comparisons test); (<bold>C, D</bold>) n = 21 (control) and 14 (<italic>npas4l<sup>−/<italic>−</italic></sup></italic>) or (<bold>I, J</bold>) n = 21 (control) and 23 (<italic>etsrp</italic> MO). Data are represented as the mean ± SEM. Standard control MO (4 ng) and <italic>etsrp</italic> MO2 (4 ng) were injected to the control group and <italic>etsrp</italic> MO group respectively at the one-cell stage (<bold>I, J, K–L’’’</bold>). (<bold>E–H’’’ and K–L’’’</bold>) Representative confocal images of pancreatic (<bold>E, F</bold>) or ectopic β-cells (<bold>G, H</bold>) of control siblings and <italic>npas4l</italic><sup><italic>−</italic>/<italic>−</italic></sup>, or ectopic β-cells in control or <italic>etsrp</italic> MO-injected (<bold>K, L</bold>) <italic>Tg(ins:Flag-NTR);Tg(ubi:Switch);Tg(drl:CreER<sup>T2</sup>)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ at 1–2 dpf, displaying β-cells in cyan with immunostaining for insulin and lineage-traced cells derived from <italic>drl</italic>-expressing mesodermal cells in red from the Cre-recombined <italic>ubi:Switch</italic>. Pancreata are outlined by solid white lines (<bold>E, F</bold>). Arrowheads point to ectopic β-cells derived from the mesoderm (<bold>H–H’’’ and L–L’’’</bold>). Selected areas in dashed squares in (<bold>H</bold>) and (<bold>L</bold>) are magnified in split (<bold>H’, H’’, L’ and L’’</bold>) and merged (<bold>H’’’ and L’’’</bold>) channels, respectively. Scale bars = 20 μm (<bold>E–H, K, and L</bold>) or 10 μm (<bold>H’–H’’’ and L’–L’’</bold>). Anatomical axes: D (dorsal), V (ventral), A (anterior), and P (posterior).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Cell population with reduced <italic>npas4l</italic> expression remains in the lateral plate mesoderm before β-cell ablation.</title><p>(<bold>A, B</bold>) Representative images of in situ hybridisation against <italic>npas4l</italic> expression in control siblings and <italic>npas4l</italic><sup>−/−</sup> zebrafish embryos at 20 hpf after a 45 min incubation to develop the expression signal. Inset (<bold>B’</bold>) displays a representative <italic>npas4l<sup>−/−</sup></italic> zebrafish embryo incubated overnight to further develop the signal. Red arrowheads point to lateral plate mesoderm expressing <italic>npas4l</italic>. (<bold>C–J</bold>) Representative images of in situ hybridisation against <italic>foxa2</italic> (<bold>C, D</bold>)<italic>, gsc</italic> (<bold>E, F</bold>)<italic>, mixl1</italic> (<bold>G, H</bold>), and <italic>ascl1b</italic> (<bold>I, J</bold>) expression in control siblings and <italic>npas4l<sup>−/−</sup></italic> zebrafish embryos at 20 hpf.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>The <italic>npas4l</italic> mutant does not display altered expression of <italic>drl</italic> in the lateral plate mesoderm.</title><p>(<bold>A, B</bold>) Representative images of in situ hybridisation against <italic>drl</italic> expression in control siblings and <italic>npas4l<sup>−/−</sup></italic> zebrafish embryos at 10 hpf.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Lateral plate mesoderm-derived cardiomyocytes are traced back to a <italic>drl</italic>-expressing lineage.</title><p>(<bold>A, B</bold>) Representative confocal images of hearts of <italic>Tg(drl:CreER<sup>T2</sup>);Tg(ubi:Switch)</italic> zebrafish larvae at three dpf after DMSO (<bold>A</bold>) or 4-OHT (<bold>B</bold>) treatment from 10 to 12 hpf. Cells with or without tamoxifen-inducible Cre recombination are shown in red and green respectively from <italic>ubi:Switch</italic>. Scale bars = 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Validation of <italic>etsrp</italic> morpholinos.</title><p>(<bold>A</bold>) Quantification of ectopic β-cells in <italic>Tg(ins:Flag-NTR)</italic> zebrafish larvae at 3 dpf after injection of random control MO (4 ng), <italic>etsrp</italic> MO1 (4 ng), or <italic>etsrp</italic> MO2 (4 ng) at one-cell stage, followed by MTZ treatment at 1–2 dpf. n = 14 (random control MO), 15 (<italic>etsrp</italic> MO1), and 17 (<italic>etsrp</italic> MO2). *p=0.0197 and **p=0.0031 (Dunn’s multiple comparisons test). (<bold>B</bold>) Quantification of ectopic β-cells in <italic>Tg(ins:Flag-NTR)</italic> zebrafish larvae at 3 dpf after injection of random control MO (3 ng), <italic>etsrp</italic> MO1 (2 ng), <italic>etsrp</italic> MO2 (1 ng), or <italic>etsrp</italic> MO1 + <italic>etsrp</italic> MO2 at the one-cell stage, followed by MTZ treatment at 1–2 dpf. n=8 (random control MO), 9 (<italic>etsrp</italic> MO1), 10 (<italic>etsrp</italic> MO2), and 10 (<italic>etsrp</italic> MO1 + <italic>etsrp</italic> MO2). **P=0.0084 (Dunn’s multiple comparisons test). Data are represented as the mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig4-figsupp4-v1.tif"/></fig></fig-group><p>Immunostaining against insulin displayed a normal set of β-cells in the pancreas of the <italic>drl</italic>-tracing larvae with or without <italic>npas4l</italic> mutation after 30 hr of regeneration (<xref ref-type="fig" rid="fig4">Figure 4C,E, and F</xref>). In line with the findings shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>, the <italic>npas4l</italic> mutation induced the formation of ectopic β-cells in the mesenchymal region (<xref ref-type="fig" rid="fig4">Figure 4D,G, and H</xref>). Furthermore, 98.9% of the ectopic β-cells in the mesenchymal region were mCherry-positive (<xref ref-type="fig" rid="fig4">Figure 4H’–H’’’</xref>), indicating that they derived from the <italic>drl</italic>-expressing mesodermal cells.</p><p>With a similar setting, we injected the <italic>drl</italic>-tracing embryos (without any <italic>npas4l</italic> mutation) with control or <italic>etsrp</italic> morpholino at the one-cell stage. Npas4l is essential for the expression of <italic>etsrp</italic>, which is a key regulator of endothelial/myeloid cell specification and vasculogenesis (<xref ref-type="bibr" rid="bib31">Reischauer et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Sumanas and Lin, 2006</xref>). Similar to the <italic>npas4l</italic> mutation, knocking down <italic>etsrp</italic> led to the formation of ectopic β-cells (<xref ref-type="fig" rid="fig4">Figure 4I–L’’’</xref>). Co-injecting lower doses of two different <italic>etsrp</italic> morpholinos (MO1 and MO2) exerted a synergistic effect on ectopic β-cell emergence (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>), suggesting that the phenotype was not due to an off-target effect. The majority of the ectopic β-cells (94.3%) in <italic>etsrp</italic> morphants was also lineage-traced back to the <italic>drl</italic>-expressing mesodermal cells, suggesting that the ectopic β-cell formation was also of mesodermal origin following <italic>etsrp</italic> knockdown.</p></sec><sec id="s2-5"><title>The mesodermal cells lose <italic>npas4l</italic> expression after differentiating into ectopic β-cells</title><p>We then further examined the autonomous role of the progenitors of endothelial and hematopoietic cells in ectopic β-cell emergence in <italic>npas4l</italic> mutants by tracing the <italic>npas4l</italic> cell lineage with a zebrafish knock-in line, <italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup></italic>. This knock-in line not only carries a +36 bp mutation in exon 2 of <italic>npas4l</italic> (<italic>npas4l<sup>bns423</sup></italic> mutation) but also expresses the transcription activator Gal4 under control of the endogenous <italic>npas4l</italic> promoter (<italic>npas4l:Gal4</italic>), allowing us to trace the <italic>npas4l</italic> lineage after crossing it into <italic>Tg(UAS:Cre);Tg(ubi:Switch)</italic> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The mesodermal cells lose <italic>npas4l</italic> expression after differentiating into ectopic β-cells.</title><p>(<bold>A</bold>) Schematics of <italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup></italic> (<italic>npas4l:Gal4</italic>), <italic>UAS:Cre</italic> and <italic>−3.5ubb:LOXP-EGFP-LOXP-mCherry</italic> (<italic>ubi:Switch</italic>). (<bold>B, C</bold>) Quantification of the pancreatic or ectopic β-cells with or without <italic>npas4l</italic>-positive mesodermal origin in control or transheterozygous <italic>npas4l<sup>s5/bns423</sup></italic> mutants at 3 dpf. ***p=0.0001 and ****P&lt;0.0001 (Šidák’s multiple comparisons test); n = 20 (control) and 21 (<italic>npas4l<sup>s5/bns423</sup></italic>). Data are represented as the mean ± SEM. (<bold>D–E’’’</bold>) Representative confocal images of ectopic β-cells and <italic>npas4l</italic>-positive lineage-traced cells in control siblings and <italic>npas4l<sup>s5/bns423</sup> Tg(ins:Flag-NTR);Tg(ubi:Switch);Tg(npas4l:Gal4);Tg(UAS:Cre)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ from 1 to 2 dpf, displaying β-cells in cyan with immunostaining for insulin and lineage-traced cells derived from <italic>npas4l</italic>-expressing mesodermal cells in red from the Cre-recombined <italic>ubi:Switch</italic>. The selected area in a dashed square in (<bold>E</bold>) is magnified in split (<bold>E’ and E’’</bold>) and merged (<bold>E’’’</bold>) channels, respectively. Arrowheads point to ectopic β-cells derived from the mesoderm (<bold>E–E’’’</bold>). (<bold>F</bold>) Schematics of <italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup></italic> (<italic>npas4l:Gal4</italic>) and <italic>UAS:EGFP</italic>. (<bold>G–G’’’</bold>) Representative confocal images of ectopic β-cells losing <italic>npas4l</italic> expression in <italic>npas4l<sup>s5/bns423</sup> Tg(ins:Flag-NTR); Tg(npas4l:Gal4);Tg(UAS:EGFP)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ from 1 to 2 dpf, displaying β-cells in magenta with immunostaining for insulin and cells expressing <italic>npas4l</italic> in green. The selected area in a dashed square in (<bold>G</bold>) is magnified in split (<bold>G’ and G’’</bold>) and merged (<bold>G’’’</bold>) channels, respectively. Arrowheads point to ectopic β-cells without <italic>npas4l</italic> expression (<bold>G–G’’’</bold>). Scale bars = 20 μm (<bold>D, E, and G</bold>) or 10 μm (<bold>E’–E’’’ and G’–G’’</bold>). Anatomical axes: D (dorsal), V (ventral), A (anterior), and P (posterior).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig5-v1.tif"/></fig><p>We obtained a transheterozygous <italic>npas4l</italic> mutant (<italic>npas4l<sup>s5/bns423</sup></italic>) by crossing this <italic>npas4l</italic> tracer carrying the <italic>npas4l<sup>bns423</sup></italic> mutation into the <italic>npas4l<sup>s5</sup></italic> mutant used in the studies above, and observed similar ectopic β-cell formation (<xref ref-type="fig" rid="fig5">Figure 5B–E’’’</xref>) as found in the homozygous <italic>npas4l<sup>s5</sup></italic> mutant (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Some of these ectopic β-cells (32.6%) could be traced back to the <italic>npas4l</italic> lineage as they were labelled by <italic>ubb:mCherry</italic> after the Cre-recombination driven by <italic>npas4l:Gal4</italic> and <italic>UAS:Cre</italic> (<xref ref-type="fig" rid="fig5">Figure 5C and E–E’’’</xref>), which further supports a mesodermal origin of the ectopic β-cells.</p><p>By crossing <italic>Tg(npas4l:Gal4)</italic> into <italic>Tg(UAS:EGFP)</italic>, the endogenous promoter activity of <italic>npas4l</italic> could be revealed by EGFP (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). The ectopic β-cells emerged in close proximity to mesodermal cells with active <italic>npas4l</italic> expression in the transheterozygous <italic>npas4l<sup>s5/bns423</sup></italic> mutants (<xref ref-type="fig" rid="fig5">Figure 5G–G’’’</xref>). However, we did not observe any ectopic β-cells with EGFP expression, suggesting that these mesodermal cells have lost the identity of the lateral plate mesoderm with <italic>npas4l</italic> expression and started to express insulin as in the endodermal pancreatic β-cells instead.</p></sec><sec id="s2-6"><title>The ectopic β-cells derive from the <italic>etsrp-</italic>expressing mesodermal lineage in <italic>etsrp</italic> morphants</title><p>To confirm the origin of the ectopic β-cell using a different lineage-tracing approach, we generated <italic>Tg(etsrp:Cre)</italic> zebrafish, based on the promoter of <italic>−2.3estrp:GFP</italic> that has been demonstrated to closely recapitulate the endogenous <italic>etsrp</italic> expression in the lateral plate mesoderm and vasculature (<xref ref-type="bibr" rid="bib46">Veldman and Lin, 2012</xref>). We then crossed <italic>Tg(etsrp:Cre)</italic> into <italic>Tg(ubi:Switch);Tg(ins:Flag-NTR)</italic>, and thereby labelling descendants of the <italic>etsrp</italic> lineage in red (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). We validated the efficiency of the <italic>etsrp</italic>-lineage tracer and revealed that the majority of <italic>kdrl</italic>-expressing endothelial cells were being traced in the intersegmental vessels (86.6%) and other vasculature (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). At the one-cell stage, we injected the <italic>etsrp</italic>-tracing embryos with control or <italic>etsrp</italic> morpholinos. After β-cell ablation by MTZ treatment at 1–2 dpf and β-cell regeneration for 30 hr ectopic β-cells formed in the <italic>etsrp</italic> morphants, and 73.9% of the ectopic β-cells were labelled in red (<xref ref-type="fig" rid="fig6">Figure 6B–E’’’</xref>), illustrating that the <italic>etsrp</italic>-expressing lineage gave rise to a significant portion of the ectopic β-cells.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The ectopic β-cells derive from the <italic>etsrp-</italic>expressing mesodermal lineage in <italic>etsrp</italic> morphants.</title><p>(<bold>A</bold>) Constructs of <italic>etsrp:Cre</italic> and <italic>−3.5ubb:LOXP-EGFP-LOXP-mCherry</italic> (<italic>ubi:Switch</italic>). (<bold>B, C</bold>) Quantification of the pancreatic or ectopic β-cells with or without <italic>etsrp</italic>-positive mesodermal origin in control or <italic>etsrp</italic> morpholino (MO)-injected larvae at 3 dpf. *p=0.0169, ***p=0.0002, and ****p&lt;0.0001 (Šidák’s multiple comparisons test); n=33 (control) and 30 (<italic>etsrp</italic> MO). Data are represented as the mean ± SEM. (<bold>D–E’’’</bold>) Representative confocal images of ectopic β-cells and <italic>etsrp</italic>-positive lineage-traced cells in control or <italic>etsrp</italic> MO-injected <italic>Tg(ins:Flag-NTR);Tg(ubi:Switch);Tg(etsrp:Cre)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ at 1–2 dpf, displaying β-cells in cyan with immunostaining for insulin and lineage-traced cells derived from <italic>etsrp</italic>-expressing mesodermal cells in red from the Cre-recombined <italic>ubi:Switch</italic>. The selected area in a dashed square in (<bold>E</bold>) is magnified in split (<bold>E’, E’’</bold>) and merged (<bold>E’’’</bold>) channels, respectively. Arrowheads point to ectopic β-cells derived from the mesoderm (<bold>E–E’’’</bold>). (<bold>F</bold>) Constructs of <italic>etsrp:Cre</italic> and <italic>ins:LOXP-mCherry-LOXP-Hsa.HIST1H2BJ-GFP</italic> (<italic>ins:CSH</italic>). (<bold>G–G’’’</bold>) Representative confocal images of ectopic β-cells derived from the <italic>etsrp</italic>-expressing lineage in <italic>etsrp</italic> MO-injected <italic>Tg(ins:Flag-NTR);Tg(ins:CSH);Tg(etsrp:Cre)</italic> zebrafish larvae at 3 dpf after β-cell ablation by MTZ at 1–2 dpf, displaying β-cells in magenta with immunostaining for insulin and lineage-traced cells derived from <italic>etsrp</italic>-expressing mesodermal cells in nuclear green from the Cre-recombined <italic>ins:CSH</italic>. The selected area in a dashed square in (<bold>G</bold>) is magnified in split (<bold>G’ and G’’</bold>) and merged (<bold>G’’’</bold>) channels, respectively. Scale bars = 20 μm (<bold>D, E, and G</bold>) or 10 μm (<bold>E’–E’’’ and G’–G’’’</bold>). Anatomical axes: D (dorsal), V (ventral), A (anterior), and P (posterior).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Most of the <italic>kdrl-</italic>expressing endothelial cells are traced back to an <italic>etsrp</italic> lineage.</title><p>(<bold>A–C</bold>) Representative confocal images of intersegmental vessels and other vasculatures in different body regions (front, mid, or tail) of <italic>Tg(etsrp:Cre);Tg(ubb:LOXP-CFP-LOXP-zgc:114046-mCherry)</italic> zebrafish larvae at 3 dpf, displaying <italic>kdrl</italic>-expressing endothelial cells in green and cells of <italic>etsrp</italic>-positive origin in nuclear red. Scale bars = 50 μm. (<bold>D, E</bold>) Quantifications of <italic>kdrl</italic>-expressing endothelial cells traced back to the <italic>etsrp</italic> lineage in the intersegmental vessels per larva at 3 dpf. n = 7; Data are represented as the mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Moreover, we replaced <italic>ubi:Switch</italic> with <italic>ins:LOXP-mCherry-LOXP-Hsa.HIST1H2BJ-GFP</italic> (<italic>ins:CSH</italic>) in the <italic>etsrp</italic>-tracing zebrafish larvae to directly trace <italic>insulin</italic>-expressing cells originating from the <italic>etsrp-</italic>expressing mesodermal lineage (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). The co-localisation of insulin staining and the nuclear green tracer further confirms the mesodermal lineage of the ectopic β-cells (<xref ref-type="fig" rid="fig6">Figure 6G–G’’’</xref>).</p><p>Together, we used three different lineage-tracing models as well as three different loss of function models, that is using the promoter of <italic>drl</italic>, <italic>npas4l</italic>, or <italic>etsrp</italic> to drive Cre in <italic>npas4l<sup>s5/s5</sup></italic> mutants<italic>, npas4l<sup>s5/bns423</sup></italic> mutants, or <italic>etsrp</italic> morphants. This suggests that the ectopic β-cell formation is not restricted to the loss of a specific gene, but rather due to the perturbation of endothelial/myeloid specification.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we first examined the role of blood vessels in β-cell regeneration in the <italic>cloche</italic> zebrafish mutant, which carries a homozygous <italic>npas4l</italic> mutation (<xref ref-type="bibr" rid="bib31">Reischauer et al., 2016</xref>). We then unexpectedly revealed β-cells regenerating ectopically in the mesenchymal area. The ectopic β-cells were likely functional because they expressed several endocrine and β-cell markers, including Isl1, <italic>mnx1</italic>, and <italic>pcsk1</italic>, and were capable of responding to glucose to induce calcium oscillations during β-cell regeneration, although we do not know if they possess all the features of bona fide β-cells. By combining in situ hybridisation, lineage tracing, and confocal microscopy, we successfully traced the origin of the ectopic β-cells to the mesodermal lineage. A recent study has reported the conversion of Etsrp-deficient vascular progenitors into skeletal muscle cells and highlighted the plasticity of mesodermal cell fate determination within the same germ layer (<xref ref-type="bibr" rid="bib4">Chestnut et al., 2020</xref>). Our data demonstrated the plasticity of β-cell differentiation across the committed germ layers in vivo, i.e., switching from a mesodermal to an endodermal fate in a regenerative setting, while gastrulation and cell fate commitment in the germ layers are considered to be irreversible in development. Ectopic pancreata have been observed before, e.g., in <italic>Hes1</italic> mutant mice (<xref ref-type="bibr" rid="bib10">Fukuda, 2006</xref>; <xref ref-type="bibr" rid="bib42">Sumazaki et al., 2004</xref>), although that has been shown to be through an expansion of the pancreas rather than through changes in cell fate determination across organs or germ layers (<xref ref-type="bibr" rid="bib18">Jørgensen et al., 2018</xref>). Our discovery is, to our knowledge, the first demonstration of ectopic β-cells with a mesodermal origin in vivo.</p><p>The recent genome-wide study with zebrafish embryos has confirmed the crucial role of <italic>npas4l</italic> in the early specification of endothelium and blood as the expressions of some endothelial and hematopoietic genes like <italic>tal1</italic>, <italic>etsrp</italic>, <italic>lmo2</italic>, <italic>gfi1aa</italic>, and <italic>gata1a</italic> were downregulated in homozygous <italic>npas4l</italic> mutants (<xref ref-type="bibr" rid="bib26">Marass et al., 2019</xref>), suggesting that some populations of mesodermal cells may not have acquired their designated cell fates and remained in a more plastic state. In line with the important role of <italic>etsrp</italic> in the endothelial cell fate determination, <xref ref-type="bibr" rid="bib4">Chestnut et al., 2020</xref> have reported a significant reduction in the cell clusters of endothelial cells and endothelial progenitor cells in homozygous <italic>etsrp</italic> mutants in a single-cell RNA-seq analysis. Interestingly, they have also shown a remarkable increase in the cluster of lateral plate mesoderm, which points to the possibility that a larger pool of more versatile mesodermal cells remained in the homozygous <italic>etsrp</italic> mutants. However, it is difficult to deduce why those mesodermal cells with perturbed cell fates would be competent to differentiate into ectopic insulin-expressing β-cells from these transcriptomic data; because the population of these competent mesodermal cells might be very small according to the number of ectopic β-cells that we observed and their single-cell RNA-seq was not performed after β-cell ablation.</p><p>Since we could trace the origin of ectopic β-cells back to <italic>drl</italic>, <italic>npas4l</italic>, and <italic>etsrp</italic> lineages, we believe that the versatile lateral plate mesoderm close to the pancreas could contribute to the β-cell regeneration in <italic>npas4l</italic> mutants or <italic>etsrp</italic> morphants. Tracing the lineages with early mesodermal, endodermal, and endocrine markers, and sorting these lineage-traced cells could be necessary for a single-cell transcriptomic study to fully understand the cellular status of this small population of versatile cells and further elucidate the underlying molecular mechanisms. Before deciphering these mechanisms, we cannot formally rule out the possibility that the mechanisms of ectopic β-cell formation in <italic>npas4l</italic> mutants and <italic>etsrp</italic> morphants could be different.</p><p>The mutated gene in the <italic>cloche</italic> mutant was named <italic>npas4l</italic> because its encoded protein shares homology with human NPAS4 (<xref ref-type="bibr" rid="bib31">Reischauer et al., 2016</xref>). Although injecting human <italic>NPAS4</italic> mRNA or zebrafish <italic>npas4l</italic> mRNA into zebrafish <italic>cloche</italic> mutant embryos at the one-cell stage could rescue the mutants, <italic>Npas4</italic> knockout mice are unlikely to share the same severe vascular and hematopoietic defects as zebrafish <italic>npas4l</italic> mutants because <italic>Npas4</italic> knockout mice survive to adulthood (<xref ref-type="bibr" rid="bib23">Lin et al., 2008</xref>). This discrepancy suggests that other members of the mammalian NPAS protein family or other proteins may be functionally redundant with NPAS4 in vascular and hematopoietic development. Mammalian NPAS4 has been shown to have important cell-autonomous functions in β-cells (<xref ref-type="bibr" rid="bib33">Sabatini et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Speckmann et al., 2016</xref>). In zebrafish, <italic>npas4a</italic> is the main <italic>npas4</italic> paralogue expressed in β-cells (<xref ref-type="bibr" rid="bib43">Tarifeño-Saldivia et al., 2017</xref>), meaning that it is unlikely the phenotype we identified early in development in <italic>npas4l</italic> mutants is related to the functions of Npas4 in β-cells. Further studies on NPAS4, related bHLH transcription factors, and ETV2 in mammals should elucidate whether inactivating such factors promotes β-cell formation with or without significantly perturbing the development of blood cells and vessels.</p><p>In summary, we have shown that the <italic>npas4l</italic> mutation and <italic>etsrp</italic> knockdown each induces ectopic regeneration of β-cells from the mesoderm. Our findings suggest a plasticity potential of mesodermal cells to differentiate into endodermal cells including β-cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Future studies on the restriction of this plasticity would not only increase our understanding of the gating role of Npas4l and Etsrp in cell fate determination but also help to exploit an alternative source for β-cell regeneration.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Npas4l/Etsrp restricts the plasticity of the mesoderm.</title><p>Mesoderm and endoderm normally follow Waddington’s landscape model to further differentiate into cells with mesodermal fates and endodermal fates, respectively, during development. However, mutating <italic>npas4l</italic> or knocking down <italic>etsrp</italic> not only abolishes the endothelial/myeloid specification but also induces plasticity of mesodermal cells to enable their differentiation into β-cells across the germ layer boundary.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65758-fig7-v1.tif"/></fig></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>npas4l<sup>s5</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7588049/">7588049</ext-link></td><td>ZFIN: ZDB-ALT-010426–6</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup></italic></td><td>Other</td><td/><td>Will be described in detail elsewhere (K.M. and D.Y.R.S., Manuscript in preparation)</td></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(ins:Hsa.HIST1H2BJ-GFP;ins:DsRed)<sup>s960</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25117518/">25117518</ext-link></td><td>ZFIN: ZDB-ALT-131001–6</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(ins:FLAG-NTR,cryaa:mCherry)<sup>s950</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22608007/">22608007</ext-link></td><td>ZFIN: ZDB-ALT-130930–5</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(ptf1a:EGFP)<sup>jh1</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16258076/">16258076</ext-link></td><td>ZFIN: ZDB-ALT-070531–2</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg<sup>BAC</sup>(hand2:EGFP)<sup>pd24</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21397850/">21397850</ext-link></td><td>ZFIN: ZDB-ALT-110128–40</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg<sup>BAC</sup>(neurod1:EGFP)<sup>nl1</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18305245/">18305245</ext-link></td><td>ZFIN: ZDB-ALT-080701–1</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg<sup>BAC</sup>(pdx1:EGFP)<sup>bns13</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31142539/">31142539</ext-link></td><td>ZFIN: ZDB-ALT-191212–6</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(mnx1:GFP)<sup>ml2</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16162647/">16162647</ext-link></td><td>ZFIN: ZDB-ALT-051025–4</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(pcsk1:EGFP)<sup>KI106</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27516442/">27516442</ext-link></td><td>ZFIN: ZDB-ALT-161115–10</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg<sup>BAC</sup>(ascl1b:EGFP-2A-Cre-ERT2)<sup>ulg006</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26329351/">26329351</ext-link></td><td>ZFIN: ZDB-ALT-160205–2</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(ins:GCaMP6s,cryaa:RFP)</italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28939870/">28939870</ext-link></td><td>ZFIN: ZDB-ALT-181221–2</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(−3.5ubb:LOXP-EGFP-LOXP-mCherry)<sup>cz1701</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21138979/">21138979</ext-link></td><td>ZFIN: ZDB-ALT-110124–1</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(−6.35drl:Cre-ERT2,cryaa:Venus)<sup>cz3333</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26306682/">26306682</ext-link></td><td>ZFIN: ZDB-ALT-160129–4</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(5xUAS:EGFP)<sup>nkuasgfp1a</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18202183/">18202183</ext-link></td><td>ZFIN: ZDB-ALT-080528–1</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(kdrl:EGFP)<sup>s843</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16251212/">16251212</ext-link></td><td>ZFIN: ZDB-ALT-050916–14</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(ubb:LOXP-CFP-LOXP-zgc:114046-mCherry)<sup>jh63</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25773748/">25773748</ext-link></td><td>ZFIN: ZDB-ALT-151007–31</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(ins:LOXP-mCherry-LOXP-Hsa.HIST1H2BJ-GFP,cryaa:Cerulean)<sup>s934</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21497092/">21497092</ext-link></td><td>ZFIN: ZDB-ALT-111031–2</td><td/></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(etsrp:iCre;cryaa:Venus)<sup>KI114</sup></italic></td><td>This paper</td><td/><td>See Materials and methods, section <italic>Zebrafish</italic></td></tr><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(UAS:Cre, cryaa:Cerulean)<sup>bns382</sup></italic></td><td>This paper</td><td/><td>See Materials and methods, section <italic>Zebrafish</italic></td></tr><tr><td>Antibody</td><td>Anti-GFP (chicken polyclonal)</td><td>Aves Labs</td><td>GFP-1020</td><td>(1:500)</td></tr><tr><td>Antibody</td><td>Anti-RFP (rabbit polyclonal)</td><td>Abcam</td><td>ab62341</td><td>(1:500)</td></tr><tr><td>Antibody</td><td>Anti-tdTomato (goat polyclonal)</td><td>MyBioSource</td><td>MBS448092</td><td>(1:500)</td></tr><tr><td>Antibody</td><td>Anti-insulin (rabbit polyclonal)</td><td>Cambridge Research Biochemicals</td><td>Customised</td><td>(1:100)</td></tr><tr><td>Antibody</td><td>Anti-pan-cadherin (rabbit polyclonal)</td><td>Sigma-Aldrich</td><td>C3678</td><td>(1:5000)</td></tr><tr><td>Antibody</td><td>Anti-islet-1-homeobox (mouse monoclonal)</td><td>DSHB</td><td>40.3A4 supernatant</td><td>(1:10)</td></tr><tr><td>Recombinant DNA reagent</td><td>p5E-MCS (plasmid)</td><td>Tol2kit</td><td>228</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>p5E-<italic>etsrp</italic> (plasmid)</td><td>This paper</td><td/><td><italic>−2.3etsrp</italic> promoter inserted into p5E-MCS</td></tr><tr><td>Recombinant DNA reagent</td><td>pME-iCre (plasmid)</td><td>Other</td><td/><td>From Kristen M. Kwan’s lab</td></tr><tr><td>Recombinant DNA reagent</td><td>p3E-polyA (plasmid)</td><td>Tol2kit</td><td>302</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pDestTol2gY (plasmid)</td><td>Other</td><td/><td>From Naoki Tsuji</td></tr><tr><td>Recombinant DNA reagent</td><td><italic>−2.3etsrp:iCre,cryaa:Venus</italic> (plasmid)</td><td>This paper</td><td/><td>See Materials and methods, section <italic>Zebrafish</italic></td></tr><tr><td>Sequence-based reagent</td><td>−2.3<italic>etsrp</italic>_FWD</td><td>This paper</td><td>PCR primer</td><td>TATAGGGCGAATTGggtaccTTCAGTAAGCAGACTCCTTCAATCA</td></tr><tr><td>Sequence-based reagent</td><td>−2.3<italic>etsrp</italic>_REV</td><td>This paper</td><td>PCR primer</td><td>AGCTGGAGCTCCAccgcggTTCGGCATACTGCTGTTGGAC</td></tr><tr><td>Sequence-based reagent</td><td>Standard control morpholino</td><td>Gene Tools</td><td>Morpholino</td><td>CCTCTTACCTCAGTTACAATTTATA</td></tr><tr><td>Sequence-based reagent</td><td>Random control morpholino</td><td>Gene Tools</td><td>Morpholino</td><td>Mixture of many oligo sequences</td></tr><tr><td>Sequence-based reagent</td><td><italic>etsrp</italic> morpholino MO1</td><td>Gene Tools</td><td>Morpholino <break/>ZFIN: ZDB-MRPHLNO-060407–2</td><td>TTGGTACATTTCCATATCTTAAAGT</td></tr><tr><td>Sequence-based reagent</td><td><italic>etsrp</italic> morpholino MO2</td><td>Gene Tools</td><td>Morpholino <break/>ZFIN: ZDB-MRPHLNO-060407–3</td><td>CACTGAGTCCTTATTTCACTATATC</td></tr><tr><td>Sequence-based reagent</td><td><italic>npas4l</italic>_ISH_FWD</td><td>This paper</td><td>PCR primer</td><td>ACTCGGGCATCAGGAGGATC</td></tr><tr><td>Sequence-based reagent</td><td><italic>npas4l</italic>_ISH_REV</td><td>This paper</td><td>PCR primer</td><td>(CCTAATACGACTCACTATAGGG)GACACCAGCATACGACACACAAC</td></tr><tr><td>Sequence-based reagent</td><td><italic>drl</italic>_ISH_FWD</td><td>This paper</td><td>PCR primer</td><td>ATGAAGAATACAACAAAACCC</td></tr><tr><td>Sequence-based reagent</td><td><italic>drl</italic>_ISH_REV</td><td>This paper</td><td>PCR primer</td><td>(CCTAATACGACTCACTATAGGG)TGAGAAGCTCTGGCCGC</td></tr><tr><td>Sequence-based reagent</td><td><italic>npas4ls5</italic>_FWD</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27411634/">27411634</ext-link></td><td>PCR primer</td><td>TTCCATCTTCTGAATCCTCCA</td></tr><tr><td>Sequence-based reagent</td><td><italic>npas4ls5</italic>_REV</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27411634/">27411634</ext-link></td><td>PCR primer</td><td>GGACAGACCCAGATACTCGT</td></tr><tr><td>Sequence-based reagent</td><td><italic>npas4ls5</italic>_SEQ</td><td>This paper</td><td>Sequencing primer</td><td>TTTCTGCCGTGAATGGATGTG</td></tr><tr><td>Commercial assay or kit</td><td>Gateway LR Clonase II Enzyme Mix</td><td>Invitrogen</td><td>11791–020</td><td/></tr><tr><td>Commercial assay or kit</td><td>Phusion High-Fidelity DNA Polymerase</td><td>Thermo Scientific</td><td>F-530L</td><td/></tr><tr><td>Commercial assay or kit</td><td>In-Fusion HD Cloning Kit</td><td>Takara Bio</td><td>639648</td><td/></tr><tr><td>Commercial assay or kit</td><td>MAXIscript T7/T3 Transcription Kit</td><td>Invitrogen</td><td>AM1324</td><td/></tr><tr><td>Chemical compound, drug</td><td>Metronidazole</td><td>Sigma-Aldrich</td><td>M3761</td><td/></tr><tr><td>Chemical compound, drug</td><td>4-Hydroxytamoxifen</td><td>Sigma-Aldrich</td><td>H7904</td><td/></tr><tr><td>Software, algorithm</td><td>ImageJ</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22930834/">22930834</ext-link></td><td/><td/></tr><tr><td>Software, algorithm</td><td>Fiji</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22743772/">22743772</ext-link></td><td/><td/></tr><tr><td>Software, algorithm</td><td>LAS X Version 3.5.5.19976</td><td>Leica</td><td/><td/></tr><tr><td>Software, algorithm</td><td>ZEN 3.1</td><td>Zeiss</td><td/><td/></tr><tr><td>Software, algorithm</td><td>GraphPad Prism 9</td><td>GraphPad Software</td><td/><td/></tr><tr><td>Other</td><td>DAPI</td><td>ThermoFisher Scientific</td><td>D1306</td><td>(1 µg/mL)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish</title><p>The following previously published mutant and transgenic zebrafish (<italic>Danio rerio</italic>) lines were used: <italic>cloche<sup>S5</sup></italic> (<xref ref-type="bibr" rid="bib7">Field et al., 2003</xref>) as the <italic>npas4l<sup>s5</sup></italic> mutant, <italic>Tg(ins:Hsa.HIST1H2BJ-GFP;ins:DsRed)<sup>s960</sup></italic> (<xref ref-type="bibr" rid="bib45">Tsuji et al., 2014</xref>) abbreviated as <italic>Tg(ins:H2BGFP;ins:DsRed)</italic>, <italic>Tg(ins:FLAG-NTR,cryaa:mCherry)<sup>s950</sup></italic> (<xref ref-type="bibr" rid="bib1">Andersson et al., 2012</xref>) abbreviated as <italic>Tg(ins:Flag-NTR)</italic>, <italic>Tg(ptf1a:EGFP)<sup>jh1</sup></italic> (<xref ref-type="bibr" rid="bib12">Godinho et al., 2005</xref>), <italic>Tg<sup>BAC</sup>(hand2:EGFP)<sup>pd24</sup></italic> (<xref ref-type="bibr" rid="bib20">Kikuchi et al., 2011</xref>), <italic>Tg<sup>BAC</sup>(neurod1:EGFP)<sup>nl1</sup></italic> (<xref ref-type="bibr" rid="bib29">Obholzer et al., 2008</xref>), <italic>Tg<sup>BAC</sup>(pdx1:EGFP)<sup>bns13</sup></italic> (<xref ref-type="bibr" rid="bib13">Helker et al., 2019</xref>), <italic>Tg(mnx1:GFP)<sup>ml2</sup></italic> (<xref ref-type="bibr" rid="bib8">Flanagan-Steet et al., 2005</xref>), <italic>Tg(pcsk1:EGFP)<sup>KI106</sup></italic> (<xref ref-type="bibr" rid="bib25">Lu et al., 2016</xref>), <italic>Tg<sup>BAC</sup>(ascl1b:EGFP-2A-Cre-ERT2)<sup>ulg006</sup></italic> (<xref ref-type="bibr" rid="bib11">Ghaye et al., 2015</xref>) abbreviated as <italic>Tg(ascl1b:EGFP)</italic>, <italic>Tg(ins:GCaMP6s,cryaa:RFP)</italic> (<xref ref-type="bibr" rid="bib38">Singh et al., 2017</xref>) generated by reinjecting the plasmid and abbreviated as <italic>Tg(ins:GCaMP6s), Tg(−3.5ubb:LOXP-EGFP-LOXP-mCherry)<sup>cz1701</sup></italic> (<xref ref-type="bibr" rid="bib27">Mosimann et al., 2011</xref>) abbreviated as <italic>Tg(ubi:Switch)</italic>, <italic>Tg(−6.35drl:Cre-ERT2,cryaa:Venus)<sup>cz3333</sup></italic> (<xref ref-type="bibr" rid="bib28">Mosimann et al., 2015</xref>) abbreviated as <italic>Tg(drl:CreER<sup>T2</sup>), Tg(5xUAS:EGFP)<sup>nkuasgfp1a</sup></italic> (<xref ref-type="bibr" rid="bib2">Asakawa et al., 2008</xref>) abbreviated as <italic>Tg(UAS:EGFP)</italic>, <italic>Tg(kdrl:EGFP)<sup>s843</sup></italic> (<xref ref-type="bibr" rid="bib17">Jin et al., 2005</xref>), <italic>Tg(ubb:LOXP-CFP-LOXP-zgc:114046-mCherry)<sup>jh63</sup></italic> (<xref ref-type="bibr" rid="bib49">Wang et al., 2015</xref>), and <italic>Tg(ins:LOXP-mCherry-LOXP-Hsa.HIST1H2BJ-GFP,cryaa:Cerulean)<sup>s934</sup></italic> (<xref ref-type="bibr" rid="bib15">Hesselson et al., 2011</xref>), which is referred to <italic>Tg(ins:mCherry)</italic> in <xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref> and <xref ref-type="video" rid="video1">Video 1</xref> and <italic>Tg(ins:CSH)</italic> in <xref ref-type="fig" rid="fig6">Figure 6</xref>.</p><p>The <italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup></italic> line (abbreviated as <italic>npas4l:Gal4</italic> or <italic>npas4l<sup>bns423</sup></italic>) was generated using the GeneWeld system (<xref ref-type="bibr" rid="bib50">Wierson et al., 2019</xref>) and will be described in detail elsewhere (K.M. and D.Y.R.S., Manuscript in preparation).</p><p>The <italic>Tg(etsrp:iCre;cryaa:Venus)<sup>KI114</sup></italic> line, abbreviated as <italic>Tg(etsrp:Cre)</italic>, was generated by the Tol2 transposon system, and the construct was made by MultiSite Gateway Cloning (Invitrogen). The amplicon of the −<italic>2.3etsrp</italic> promoter was synthesised from zebrafish genomic DNA with a forward primer 5’-<named-content content-type="sequence">TATAGGGCGAATTGggtaccTTCAGTAAGCAGACTCCTTCAATCA</named-content>-3’ and a reverse primer 5’-<named-content content-type="sequence">AGCTGGAGCTCCAccgcggTTCGGCATACTGCTGTTGGAC</named-content>-3’ by Phusion High-Fidelity DNA Polymerase (Thermo Scientific) as an insert for In-Fusion Cloning (Takara Bio) with p5E-MCS using restriction sites KpnI and SacII to yield p5E-<italic>etsrp</italic>. Subsequently, p5E-<italic>etsrp</italic>, pME-iCre, p3E-polyA, and pDestTol2gY were used for the LR reaction to generate the construct <italic>−2.3etsrp:iCre,cryaa:Venus</italic>. Expressing <italic>iCre</italic> (improved Cre recombinase) by an <italic>etsrp</italic> promoter would cleave the <italic>loxP</italic> sites of reporters, e.g. <italic>ubi:Switch</italic>, which allows us to trace the descendants differentiated from an <italic>etsrp</italic> lineage.</p><p>The <italic>Tg(UAS:Cre, cryaa:Cerulean)<sup>bns382</sup></italic> line, abbreviated as <italic>Tg(UAS:Cre)</italic>, was generated via Tol2-mediated transgenesis by injecting a construct that placed the Cre recombinase coding sequence downstream of five tandem copies of the upstream activation sequence (UAS). The eye-marker <italic>cryaa:Cerulean</italic> cassette (<xref ref-type="bibr" rid="bib14">Hesselson et al., 2009</xref>) was inserted downstream of Cre in the reverse orientation using 0.56 kb of the <italic>cryaa</italic> promoter (<xref ref-type="bibr" rid="bib21">Kurita et al., 2003</xref>).</p><p>Males and females ranging in age from 3 months to 2 years were used for breeding to obtain new offspring for experiments. Individuals were sorted into the control sibling group (<italic>npas4l<sup>+/+</sup></italic>, <italic>npas4l<sup>s5/+</sup>,</italic> or <italic>npas4l<sup>bns423/+</sup></italic>) and the <italic>npas4l</italic> mutant group (<italic>npas4l<sup>s5/s5</sup></italic> or <italic>npas4l<sup>s5/bns423</sup></italic>) based on the characteristic pericardial oedema and blood-cell deficit. Zebrafish larvae were allocated into different experimental groups based on their phenotypes and genotypes in experiments involving <italic>cloche</italic> mutants. In morpholino knockdown experiments, zebrafish embryos were randomly assigned to each experimental condition for injection. Experimental procedures were performed on the zebrafish from 10 hpf to 3 dpf before the completion of sex determination and gonad differentiation. All zebrafish, except <italic>npas4l</italic> mutants and <italic>etsrp</italic> morphants, appeared healthy and survived to adulthood. The <italic>npas4l</italic> mutants exhibited pericardial oedema, bell-shaped hearts, and blood deficits, as previously reported (<xref ref-type="bibr" rid="bib40">Stainier et al., 1995</xref>). The <italic>etsrp</italic> morphants had similar phenotypes. All studies involving zebrafish were performed in accordance with local guidelines and regulations and approved by regional authorities.</p></sec><sec id="s4-2"><title>Chemical ablation of β-cells</title><p>As in our previous report (<xref ref-type="bibr" rid="bib36">Schulz et al., 2016</xref>), we ablated β-cells by incubating the β-cell ablation model <italic>Tg(ins:Flag-NTR)</italic> zebrafish in E3 medium supplemented with 10 mM metronidazole (MTZ, Sigma-Aldrich), 1% DMSO (VWR), and 0.2 mM 1-phenyl-2-thiourea (Acros Organics) for 24 hr from 1 to 2 dpf.</p></sec><sec id="s4-3"><title>Microinjection of morpholinos</title><p>Standard control morpholino (5’-<named-content content-type="sequence">CCTCTTACCTCAGTTACAATTTATA</named-content>-3’), random control morpholino, <italic>etsrp</italic> morpholino MO1 (5’-<named-content content-type="sequence">TTGGTACATTTCCATATCTTAAAGT</named-content>-3’), and MO2 (5’-<named-content content-type="sequence">CACTGAGTCCTTATTTCACTATATC</named-content>-3’) (<xref ref-type="bibr" rid="bib41">Sumanas and Lin, 2006</xref>) were purchased from Gene Tools, LLC. Morpholinos were injected into the one-cell-stage zebrafish embryos at the doses specified in the figure legends.</p></sec><sec id="s4-4"><title>Lineage tracing by tamoxifen-inducible cre recombinase</title><p>To genetically trace the mesodermal lineage, we treated <italic>Tg(ins:Flag-NTR);Tg(ubi:Switch);Tg(drl:CreER<sup>T2</sup>)</italic> zebrafish embryos with 10 μM 4-OHT (Sigma-Aldrich) in E3 medium in 90 mm Petri dishes, with approximately 60 individuals per dish, from 10 to 12 hpf. Upon induction by 4-OHT, cytoplasmic CreER<sup>T2</sup> would be translocated to the nucleus to excise the loxP-flanked EGFP to enable mCherry expression in <italic>drl</italic>-expressing cells and their descendants, indicating a mesodermal lineage.</p></sec><sec id="s4-5"><title>Sample fixation for immunostaining</title><p>Before fixing the zebrafish larvae, we confirmed the presence of the transgenes by determining the corresponding fluorescent markers and subsequently examined them under a widefield fluorescence microscope LEICA M165 FC (Leica Microsystems). We then euthanised the zebrafish larvae with 250 mg/L tricaine (Sigma-Aldrich) in E3 medium followed by washing in distilled water three times. We fixed the samples in 4% formaldehyde (Sigma-Aldrich) in PBS (ThermoFisher Scientific) at 4°C overnight. After washing away the fixative with PBS three times, we removed the skin and crystallised yolk of the zebrafish larvae by forceps under the microscope to expose the pancreas and mesenchyme for immunostaining.</p></sec><sec id="s4-6"><title>Immunostaining and confocal imaging</title><p>As in our previous report (<xref ref-type="bibr" rid="bib24">Liu et al., 2018</xref>), we started immunostaining by incubating the zebrafish samples in blocking solution (0.3% Triton X-100, 4% BSA and 0.02% sodium azide from Sigma-Aldrich in PBS) at room temperature for 1 hr. We then incubated the samples in blocking solution with primary antibodies at 4°C overnight. After removing the primary antibodies, we washed the samples with washing buffer (0.3% Triton X-100 in PBS) eight times at room temperature for 2 hr. Afterwards, we incubated the samples in blocking solution with fluorescent dye-conjugated secondary antibodies and the nuclear counterstain DAPI (ThermoFisher Scientific) if applicable at 4°C overnight. Next, we removed the secondary antibodies and nuclear counterstain and washed the samples with washing buffer eight times at room temperature for 2 hr. The following primary antibodies were used: anti-GFP (1:500, Aves Labs, GFP-1020), anti-RFP (1:500, Abcam, ab62341), anti-tdTomato (1:500, MyBioSource, MBS448092), anti-insulin (1:100, Cambridge Research Biochemicals, customised), anti-pan-cadherin (1:5000, Sigma, C3678), and anti-islet-1-homeobox (1:10, DSHB, 40.3A4 supernatant).</p><p>Before confocal imaging, we mounted the stained samples in VECTASHIELD Antifade Mounting Medium (Vector Laboratories) on microscope slides with the pancreas facing the cover slips. We imaged the pancreas and neighbouring mesenchyme of every zebrafish sample that we had mounted with the confocal laser scanning microscopy platform Leica TCS SP8 and LAS X (Leica Microsystems). We analysed the images by Fiji (<xref ref-type="bibr" rid="bib34">Schindelin et al., 2012</xref>) and classified a β-cell as pancreatic when it was located in the pancreas, as delineated by pan-cadherin, DAPI, or <italic>ptf1a:EGFP</italic> labelling. The insulin-positive cells outside of the pancreas were defined as ectopic β-cells.</p></sec><sec id="s4-7"><title>Live calcium imaging of zebrafish β-cells</title><p>Imaging of pancreatic and ectopic β-cells was performed on 3 dpf <italic>Tg(ins:GCaMP6s);Tg(ins:mCherry);Tg(ins:Flag-NTR) npas4l</italic> mutants on a ZEISS LSM 980 confocal microscope equipped with a W Plan-Apochromat ×20/1 NA water correction lens and operated by ZEN. The GCaMP6s and mCherry signals from β-cells were simultaneously acquired using the 488 nm and 587 nm laser lines. The GCaMP6s signal was rendered in green, and the mCherry signal was rendered in red. Time series recordings were taken with an in-plane resolution of 1024 × 1024 pixels and a fully open pinhole to maximise light capture. The videos were recorded for 400 cycles, with approximately 2 s acquisition time per frame. Videos were analysed in ImageJ (<xref ref-type="bibr" rid="bib35">Schneider et al., 2012</xref>).</p></sec><sec id="s4-8"><title>Whole-mount in situ hybridisation</title><p>Zebrafish embryos at 10 and 20 dpf were fixed with 4% paraformaldehyde in PBS at 4°C overnight. Whole-mount in situ hybridisation was performed according to the method in a previous report (<xref ref-type="bibr" rid="bib44">Thisse and Thisse, 2008</xref>). Probes against <italic>npas4l</italic> and <italic>drl</italic> were synthesised from transcription templates from PCR using bud-stage zebrafish cDNA, Phusion High-Fidelity DNA Polymerase (Thermo Scientific) and primer pairs 5’-<named-content content-type="sequence">ACTCGGGCATCAGGAGGATC</named-content>-3’ plus 5’-(<named-content content-type="sequence">CCTAATACGACTCACTATAGGG</named-content>) <named-content content-type="sequence">GACACCAGCATACGACACACAAC</named-content>-3’ for <italic>npas4l</italic>, and 5’-<named-content content-type="sequence">ATGAAGAATACAACAAAACCC</named-content>-3’ plus 5’-(<named-content content-type="sequence">CCTAATACGACTCACTATAGGG</named-content>) <named-content content-type="sequence">TGAGAAGCTCTGGCCGC</named-content>-3’ for <italic>drl</italic>, respectively. Plasmids carrying probe templates of <italic>foxa2</italic>, <italic>gsc</italic>, <italic>mixl1</italic>, and <italic>ascl1b</italic> were linearised by corresponding restriction enzymes. T7 (except <italic>foxa2</italic> probe with T3) was employed for transcription, and digoxigenin (Roche) was used for labelling. To genotype the <italic>npas4l<sup>s5</sup></italic> mutants, PCR was performed using gDNA from the imaged samples and primers 5’-<named-content content-type="sequence">TTCCATCTTCTGAATCCTCCA</named-content>-3’ plus 5’-<named-content content-type="sequence">GGACAGACCCAGATACTCGT</named-content>-3’ at the conditions previously reported (<xref ref-type="bibr" rid="bib31">Reischauer et al., 2016</xref>). The PCR products were then sent for sequencing with the following primer 5’-<named-content content-type="sequence">TTTCTGCCGTGAATGGATGTG</named-content>-3’ (Eurofins Genomics).</p></sec><sec id="s4-9"><title>Statistical analysis</title><p>Similar experiments were performed at least twice independently. The number of cells in the confocal microscopy images was all quantified manually with the aid of the Multipoint Tool from Fiji (<xref ref-type="bibr" rid="bib34">Schindelin et al., 2012</xref>). Data were then analysed with Prism (GraphPad). Statistical analyses were carried out by two-tailed t-tests when two groups were analysed and by ANOVA when more than two groups were analysed. We have presented the results as the mean values ± SEM and considered p-values ≤ 0.05 to be statistically significant. The n number represents the number of zebrafish individuals in each group of each experiment.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are very thankful to Abdeljabbar El Manira for making equipment available for calcium imaging; Dirk Meyer for plasmids carrying probe templates of <italic>foxa2</italic>, <italic>gsc</italic>, <italic>mixl1</italic>, and <italic>ascl1b</italic>; Christian Mosimann for sharing the <italic>Tg(−6.35drl:Cre-ERT2,cryaa:Venus)<sup>cz3333</sup></italic> line and information; and Naoki Tsuji for the pDestTol2gY plasmid.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Supervision, Funding acquisition, Investigation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: This study was performed in accordance with the recommendations of Karolinska Institutet. All of the animals were handled according to approved institutional animal care and in accordance with rules in L150 from the Swedish Board of Agriculture. The protocol was approved by Stockholms Djurförsöksetiska nämnd (Permit Number: N145/15 and 6848-2020).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Source data for all Figures.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65758-data1-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-65758-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and source data files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>O</given-names></name><name><surname>Adams</surname> <given-names>BA</given-names></name><name><surname>Yoo</surname> <given-names>D</given-names></name><name><surname>Ellis</surname> <given-names>GC</given-names></name><name><surname>Gut</surname> <given-names>P</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>German</surname> <given-names>MS</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Adenosine signaling promotes regeneration of pancreatic β cells in vivo</article-title><source>Cell Metabolism</source><volume>15</volume><fpage>885</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.04.018</pub-id><pub-id pub-id-type="pmid">22608007</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakawa</surname> <given-names>K</given-names></name><name><surname>Suster</surname> <given-names>ML</given-names></name><name><surname>Mizusawa</surname> <given-names>K</given-names></name><name><surname>Nagayoshi</surname> <given-names>S</given-names></name><name><surname>Kotani</surname> <given-names>T</given-names></name><name><surname>Urasaki</surname> <given-names>A</given-names></name><name><surname>Kishimoto</surname> <given-names>Y</given-names></name><name><surname>Hibi</surname> <given-names>M</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish</article-title><source>PNAS</source><volume>105</volume><fpage>1255</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1073/pnas.0704963105</pub-id><pub-id pub-id-type="pmid">18202183</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname> <given-names>GS</given-names></name><name><surname>Zacharias</surname> <given-names>DA</given-names></name><name><surname>Tsien</surname> <given-names>RY</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral</article-title><source>PNAS</source><volume>97</volume><fpage>11984</fpage><lpage>11989</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.22.11984</pub-id><pub-id pub-id-type="pmid">11050229</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chestnut</surname> <given-names>B</given-names></name><name><surname>Casie Chetty</surname> <given-names>S</given-names></name><name><surname>Koenig</surname> <given-names>AL</given-names></name><name><surname>Sumanas</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptomic analysis identifies the conversion of zebrafish Etv2-deficient vascular progenitors into skeletal muscle</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2796</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16515-y</pub-id><pub-id pub-id-type="pmid">32493965</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clements</surname> <given-names>D</given-names></name><name><surname>Woodland</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Changes in embryonic cell fate produced by expression of an endodermal transcription factor, Xsox17</article-title><source>Mechanisms of Development</source><volume>99</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S0925-4773(00)00476-7</pub-id><pub-id pub-id-type="pmid">11091074</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curado</surname> <given-names>S</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Jungblut</surname> <given-names>B</given-names></name><name><surname>Mumm</surname> <given-names>J</given-names></name><name><surname>Schroeter</surname> <given-names>E</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Conditional targeted cell ablation in zebrafish: a new tool for regeneration studies</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>1025</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21100</pub-id><pub-id pub-id-type="pmid">17326133</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname> <given-names>HA</given-names></name><name><surname>Dong</surname> <given-names>PD</given-names></name><name><surname>Beis</surname> <given-names>D</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Formation of the digestive system in zebrafish. II. pancreas morphogenesis</article-title><source>Developmental Biology</source><volume>261</volume><fpage>197</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/S0012-1606(03)00308-7</pub-id><pub-id pub-id-type="pmid">12941629</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flanagan-Steet</surname> <given-names>H</given-names></name><name><surname>Fox</surname> <given-names>MA</given-names></name><name><surname>Meyer</surname> <given-names>D</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations</article-title><source>Development</source><volume>132</volume><fpage>4471</fpage><lpage>4481</lpage><pub-id pub-id-type="doi">10.1242/dev.02044</pub-id><pub-id pub-id-type="pmid">16162647</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flasse</surname> <given-names>LC</given-names></name><name><surname>Pirson</surname> <given-names>JL</given-names></name><name><surname>Stern</surname> <given-names>DG</given-names></name><name><surname>Von Berg</surname> <given-names>V</given-names></name><name><surname>Manfroid</surname> <given-names>I</given-names></name><name><surname>Peers</surname> <given-names>B</given-names></name><name><surname>Voz</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ascl1b and Neurod1, instead of Neurog3, control pancreatic endocrine cell fate in zebrafish</article-title><source>BMC Biology</source><volume>11</volume><elocation-id>78</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7007-11-78</pub-id><pub-id pub-id-type="pmid">23835295</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ectopic pancreas formation in Hes1-knockout mice reveals plasticity of endodermal progenitors of the gut, bile duct, and pancreas</article-title><source>Journal of Clinical Investigation</source><volume>116</volume><fpage>1484</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1172/JCI27704</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaye</surname> <given-names>AP</given-names></name><name><surname>Bergemann</surname> <given-names>D</given-names></name><name><surname>Tarifeño-Saldivia</surname> <given-names>E</given-names></name><name><surname>Flasse</surname> <given-names>LC</given-names></name><name><surname>Von Berg</surname> <given-names>V</given-names></name><name><surname>Peers</surname> <given-names>B</given-names></name><name><surname>Voz</surname> <given-names>ML</given-names></name><name><surname>Manfroid</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Progenitor potential of nkx6.1-expressing cells throughout zebrafish life and during beta cell regeneration</article-title><source>BMC Biology</source><volume>13</volume><elocation-id>70</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-015-0179-4</pub-id><pub-id pub-id-type="pmid">26329351</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godinho</surname> <given-names>L</given-names></name><name><surname>Mumm</surname> <given-names>JS</given-names></name><name><surname>Williams</surname> <given-names>PR</given-names></name><name><surname>Schroeter</surname> <given-names>EH</given-names></name><name><surname>Koerber</surname> <given-names>A</given-names></name><name><surname>Park</surname> <given-names>SW</given-names></name><name><surname>Leach</surname> <given-names>SD</given-names></name><name><surname>Wong</surname> <given-names>RO</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Targeting of amacrine cell neurites to appropriate synaptic laminae in the developing zebrafish retina</article-title><source>Development</source><volume>132</volume><fpage>5069</fpage><lpage>5079</lpage><pub-id pub-id-type="doi">10.1242/dev.02075</pub-id><pub-id pub-id-type="pmid">16258076</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helker</surname> <given-names>CSM</given-names></name><name><surname>Mullapudi</surname> <given-names>S-T</given-names></name><name><surname>Mueller</surname> <given-names>LM</given-names></name><name><surname>Preussner</surname> <given-names>J</given-names></name><name><surname>Tunaru</surname> <given-names>S</given-names></name><name><surname>Skog</surname> <given-names>O</given-names></name><name><surname>Kwon</surname> <given-names>H-B</given-names></name><name><surname>Kreuder</surname> <given-names>F</given-names></name><name><surname>Lancman</surname> <given-names>JJ</given-names></name><name><surname>Bonnavion</surname> <given-names>R</given-names></name><name><surname>Dong</surname> <given-names>PDS</given-names></name><name><surname>Looso</surname> <given-names>M</given-names></name><name><surname>Offermanns</surname> <given-names>S</given-names></name><name><surname>Korsgren</surname> <given-names>O</given-names></name><name><surname>Spagnoli</surname> <given-names>FM</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Whole organism small molecule screen identifies novel regulators of pancreatic endocrine development</article-title><source>Development</source><volume>28</volume><elocation-id>172569</elocation-id><pub-id pub-id-type="doi">10.1242/dev.172569</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesselson</surname> <given-names>D</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Beinat</surname> <given-names>M</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Distinct populations of quiescent and proliferative pancreatic beta-cells identified by HOTcre mediated labeling</article-title><source>PNAS</source><volume>106</volume><fpage>14896</fpage><lpage>14901</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906348106</pub-id><pub-id pub-id-type="pmid">19706417</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesselson</surname> <given-names>D</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Suppression of Ptf1a activity induces acinar-to-endocrine conversion</article-title><source>Current Biology</source><volume>21</volume><fpage>712</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2011.03.041</pub-id><pub-id pub-id-type="pmid">21497092</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>P</given-names></name><name><surname>He</surname> <given-names>Z</given-names></name><name><surname>Ji</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>H</given-names></name><name><surname>Xiang</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Hui</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors</article-title><source>Nature</source><volume>475</volume><fpage>386</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1038/nature10116</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>SW</given-names></name><name><surname>Beis</surname> <given-names>D</given-names></name><name><surname>Mitchell</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cellular and molecular analyses of vascular tube and lumen formation in zebrafish</article-title><source>Development</source><volume>132</volume><fpage>5199</fpage><lpage>5209</lpage><pub-id pub-id-type="doi">10.1242/dev.02087</pub-id><pub-id pub-id-type="pmid">16251212</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jørgensen</surname> <given-names>MC</given-names></name><name><surname>de Lichtenberg</surname> <given-names>KH</given-names></name><name><surname>Collin</surname> <given-names>CA</given-names></name><name><surname>Klinck</surname> <given-names>R</given-names></name><name><surname>Ekberg</surname> <given-names>JH</given-names></name><name><surname>Engelstoft</surname> <given-names>MS</given-names></name><name><surname>Lickert</surname> <given-names>H</given-names></name><name><surname>Serup</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neurog3-dependent pancreas dysgenesis causes ectopic pancreas in Hes1 mutant mice</article-title><source>Development</source><volume>145</volume><elocation-id>dev163568</elocation-id><pub-id pub-id-type="doi">10.1242/dev.163568</pub-id><pub-id pub-id-type="pmid">30093553</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname> <given-names>Y</given-names></name><name><surname>Agathon</surname> <given-names>A</given-names></name><name><surname>Alexander</surname> <given-names>J</given-names></name><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Waldron</surname> <given-names>S</given-names></name><name><surname>Yelon</surname> <given-names>D</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Casanova encodes a novel Sox-related protein necessary and sufficient for early endoderm formation in zebrafish</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>1493</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1101/gad.892301</pub-id><pub-id pub-id-type="pmid">11410530</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname> <given-names>K</given-names></name><name><surname>Holdway</surname> <given-names>JE</given-names></name><name><surname>Major</surname> <given-names>RJ</given-names></name><name><surname>Blum</surname> <given-names>N</given-names></name><name><surname>Dahn</surname> <given-names>RD</given-names></name><name><surname>Begemann</surname> <given-names>G</given-names></name><name><surname>Poss</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Retinoic acid production by endocardium and epicardium is an injury response essential for zebrafish heart regeneration</article-title><source>Developmental Cell</source><volume>20</volume><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.01.010</pub-id><pub-id pub-id-type="pmid">21397850</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurita</surname> <given-names>R</given-names></name><name><surname>Sagara</surname> <given-names>H</given-names></name><name><surname>Aoki</surname> <given-names>Y</given-names></name><name><surname>Link</surname> <given-names>BA</given-names></name><name><surname>Arai</surname> <given-names>K</given-names></name><name><surname>Watanabe</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Suppression of Lens growth by alphaA-crystallin promoter-driven expression of diphtheria toxin results in disruption of retinal cell organization in zebrafish</article-title><source>Developmental Biology</source><volume>255</volume><fpage>113</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/S0012-1606(02)00079-9</pub-id><pub-id pub-id-type="pmid">12618137</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lickert</surname> <given-names>H</given-names></name><name><surname>Kutsch</surname> <given-names>S</given-names></name><name><surname>Kanzler</surname> <given-names>B</given-names></name><name><surname>Tamai</surname> <given-names>Y</given-names></name><name><surname>Taketo</surname> <given-names>MM</given-names></name><name><surname>Kemler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Formation of multiple hearts in mice following deletion of beta-<italic>catenin</italic> in the embryonic endoderm</article-title><source>Developmental Cell</source><volume>3</volume><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/S1534-5807(02)00206-X</pub-id><pub-id pub-id-type="pmid">12194849</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Bloodgood</surname> <given-names>BL</given-names></name><name><surname>Hauser</surname> <given-names>JL</given-names></name><name><surname>Lapan</surname> <given-names>AD</given-names></name><name><surname>Koon</surname> <given-names>AC</given-names></name><name><surname>Kim</surname> <given-names>TK</given-names></name><name><surname>Hu</surname> <given-names>LS</given-names></name><name><surname>Malik</surname> <given-names>AN</given-names></name><name><surname>Greenberg</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Activity-dependent regulation of inhibitory synapse development by Npas4</article-title><source>Nature</source><volume>455</volume><fpage>1198</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1038/nature07319</pub-id><pub-id pub-id-type="pmid">18815592</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>KC</given-names></name><name><surname>Leuckx</surname> <given-names>G</given-names></name><name><surname>Sakano</surname> <given-names>D</given-names></name><name><surname>Seymour</surname> <given-names>PA</given-names></name><name><surname>Mattsson</surname> <given-names>CL</given-names></name><name><surname>Rautio</surname> <given-names>L</given-names></name><name><surname>Staels</surname> <given-names>W</given-names></name><name><surname>Verdonck</surname> <given-names>Y</given-names></name><name><surname>Serup</surname> <given-names>P</given-names></name><name><surname>Kume</surname> <given-names>S</given-names></name><name><surname>Heimberg</surname> <given-names>H</given-names></name><name><surname>Andersson</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inhibition of Cdk5 promotes β-Cell differentiation from ductal progenitors</article-title><source>Diabetes</source><volume>67</volume><fpage>58</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.2337/db16-1587</pub-id><pub-id pub-id-type="pmid">28986398</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>KC</given-names></name><name><surname>Schulz</surname> <given-names>N</given-names></name><name><surname>Karampelias</surname> <given-names>C</given-names></name><name><surname>Charbord</surname> <given-names>J</given-names></name><name><surname>Hilding</surname> <given-names>A</given-names></name><name><surname>Rautio</surname> <given-names>L</given-names></name><name><surname>Bertolino</surname> <given-names>P</given-names></name><name><surname>Östenson</surname> <given-names>CG</given-names></name><name><surname>Brismar</surname> <given-names>K</given-names></name><name><surname>Andersson</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>IGFBP1 increases β-cell regeneration by promoting α- to β-cell transdifferentiation</article-title><source>The EMBO Journal</source><volume>35</volume><fpage>2026</fpage><lpage>2044</lpage><pub-id pub-id-type="doi">10.15252/embj.201592903</pub-id><pub-id pub-id-type="pmid">27516442</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marass</surname> <given-names>M</given-names></name><name><surname>Beisaw</surname> <given-names>A</given-names></name><name><surname>Gerri</surname> <given-names>C</given-names></name><name><surname>Luzzani</surname> <given-names>F</given-names></name><name><surname>Fukuda</surname> <given-names>N</given-names></name><name><surname>Günther</surname> <given-names>S</given-names></name><name><surname>Kuenne</surname> <given-names>C</given-names></name><name><surname>Reischauer</surname> <given-names>S</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-wide strategies reveal target genes of Npas4l associated with vascular development in zebrafish</article-title><source>Development</source><volume>12</volume><elocation-id>173427</elocation-id><pub-id pub-id-type="doi">10.1242/dev.173427</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosimann</surname> <given-names>C</given-names></name><name><surname>Kaufman</surname> <given-names>CK</given-names></name><name><surname>Li</surname> <given-names>P</given-names></name><name><surname>Pugach</surname> <given-names>EK</given-names></name><name><surname>Tamplin</surname> <given-names>OJ</given-names></name><name><surname>Zon</surname> <given-names>LI</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ubiquitous transgene expression and Cre-based recombination driven by the <italic>ubiquitin</italic> promoter in zebrafish</article-title><source>Development</source><volume>138</volume><fpage>169</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1242/dev.059345</pub-id><pub-id pub-id-type="pmid">21138979</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosimann</surname> <given-names>C</given-names></name><name><surname>Panáková</surname> <given-names>D</given-names></name><name><surname>Werdich</surname> <given-names>AA</given-names></name><name><surname>Musso</surname> <given-names>G</given-names></name><name><surname>Burger</surname> <given-names>A</given-names></name><name><surname>Lawson</surname> <given-names>KL</given-names></name><name><surname>Carr</surname> <given-names>LA</given-names></name><name><surname>Nevis</surname> <given-names>KR</given-names></name><name><surname>Sabeh</surname> <given-names>MK</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name><name><surname>DiBiase</surname> <given-names>A</given-names></name><name><surname>Burns</surname> <given-names>CE</given-names></name><name><surname>Burns</surname> <given-names>CG</given-names></name><name><surname>MacRae</surname> <given-names>CA</given-names></name><name><surname>Zon</surname> <given-names>LI</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chamber identity programs drive early functional partitioning of the heart</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8146</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9146</pub-id><pub-id pub-id-type="pmid">26306682</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obholzer</surname> <given-names>N</given-names></name><name><surname>Wolfson</surname> <given-names>S</given-names></name><name><surname>Trapani</surname> <given-names>JG</given-names></name><name><surname>Mo</surname> <given-names>W</given-names></name><name><surname>Nechiporuk</surname> <given-names>A</given-names></name><name><surname>Busch-Nentwich</surname> <given-names>E</given-names></name><name><surname>Seiler</surname> <given-names>C</given-names></name><name><surname>Sidi</surname> <given-names>S</given-names></name><name><surname>Söllner</surname> <given-names>C</given-names></name><name><surname>Duncan</surname> <given-names>RN</given-names></name><name><surname>Boehland</surname> <given-names>A</given-names></name><name><surname>Nicolson</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Vesicular glutamate transporter 3 is required for synaptic transmission in zebrafish hair cells</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>2110</fpage><lpage>2118</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5230-07.2008</pub-id><pub-id pub-id-type="pmid">18305245</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname> <given-names>L</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Cell-autonomous and non-autonomous requirements for the zebrafish gene cloche in hematopoiesis</article-title><source>Development</source><volume>126</volume><fpage>2643</fpage><lpage>2651</lpage><pub-id pub-id-type="doi">10.1242/dev.126.12.2643</pub-id><pub-id pub-id-type="pmid">10331976</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reischauer</surname> <given-names>S</given-names></name><name><surname>Stone</surname> <given-names>OA</given-names></name><name><surname>Villasenor</surname> <given-names>A</given-names></name><name><surname>Chi</surname> <given-names>N</given-names></name><name><surname>Jin</surname> <given-names>SW</given-names></name><name><surname>Martin</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>MT</given-names></name><name><surname>Fukuda</surname> <given-names>N</given-names></name><name><surname>Marass</surname> <given-names>M</given-names></name><name><surname>Witty</surname> <given-names>A</given-names></name><name><surname>Fiddes</surname> <given-names>I</given-names></name><name><surname>Kuo</surname> <given-names>T</given-names></name><name><surname>Chung</surname> <given-names>WS</given-names></name><name><surname>Salek</surname> <given-names>S</given-names></name><name><surname>Lerrigo</surname> <given-names>R</given-names></name><name><surname>Alsiö</surname> <given-names>J</given-names></name><name><surname>Luo</surname> <given-names>S</given-names></name><name><surname>Tworus</surname> <given-names>D</given-names></name><name><surname>Augustine</surname> <given-names>SM</given-names></name><name><surname>Mucenieks</surname> <given-names>S</given-names></name><name><surname>Nystedt</surname> <given-names>B</given-names></name><name><surname>Giraldez</surname> <given-names>AJ</given-names></name><name><surname>Schroth</surname> <given-names>GP</given-names></name><name><surname>Andersson</surname> <given-names>O</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cloche is a bHLH-PAS transcription factor that drives haemato-vascular specification</article-title><source>Nature</source><volume>535</volume><fpage>294</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1038/nature18614</pub-id><pub-id pub-id-type="pmid">27411634</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ring</surname> <given-names>KL</given-names></name><name><surname>Tong</surname> <given-names>LM</given-names></name><name><surname>Balestra</surname> <given-names>ME</given-names></name><name><surname>Javier</surname> <given-names>R</given-names></name><name><surname>Andrews-Zwilling</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>G</given-names></name><name><surname>Walker</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>WR</given-names></name><name><surname>Kreitzer</surname> <given-names>AC</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor</article-title><source>Cell Stem Cell</source><volume>11</volume><fpage>100</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.05.018</pub-id><pub-id pub-id-type="pmid">22683203</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatini</surname> <given-names>PV</given-names></name><name><surname>Speckmann</surname> <given-names>T</given-names></name><name><surname>Nian</surname> <given-names>C</given-names></name><name><surname>Glavas</surname> <given-names>MM</given-names></name><name><surname>Wong</surname> <given-names>CK</given-names></name><name><surname>Yoon</surname> <given-names>JS</given-names></name><name><surname>Kin</surname> <given-names>T</given-names></name><name><surname>Shapiro</surname> <given-names>AMJ</given-names></name><name><surname>Gibson</surname> <given-names>WT</given-names></name><name><surname>Verchere</surname> <given-names>CB</given-names></name><name><surname>Lynn</surname> <given-names>FC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuronal PAS domain protein 4 suppression of oxygen sensing optimizes metabolism during excitation of neuroendocrine cells</article-title><source>Cell Reports</source><volume>22</volume><fpage>163</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.033</pub-id><pub-id pub-id-type="pmid">29298418</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>CA</given-names></name><name><surname>Rasband</surname> <given-names>WS</given-names></name><name><surname>Eliceiri</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NIH image to ImageJ: 25 years of image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>671</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmid">22930834</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>N</given-names></name><name><surname>Liu</surname> <given-names>K-C</given-names></name><name><surname>Charbord</surname> <given-names>J</given-names></name><name><surname>Mattsson</surname> <given-names>CL</given-names></name><name><surname>Tao</surname> <given-names>L</given-names></name><name><surname>Tworus</surname> <given-names>D</given-names></name><name><surname>Andersson</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Critical role for Adenosine receptor A2a in β-cell proliferation</article-title><source>Molecular Metabolism</source><volume>5</volume><fpage>1138</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2016.09.006</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekiya</surname> <given-names>S</given-names></name><name><surname>Suzuki</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors</article-title><source>Nature</source><volume>475</volume><fpage>390</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1038/nature10263</pub-id><pub-id pub-id-type="pmid">21716291</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>SP</given-names></name><name><surname>Janjuha</surname> <given-names>S</given-names></name><name><surname>Hartmann</surname> <given-names>T</given-names></name><name><surname>Kayisoglu</surname> <given-names>Ö</given-names></name><name><surname>Konantz</surname> <given-names>J</given-names></name><name><surname>Birke</surname> <given-names>S</given-names></name><name><surname>Murawala</surname> <given-names>P</given-names></name><name><surname>Alfar</surname> <given-names>EA</given-names></name><name><surname>Murata</surname> <given-names>K</given-names></name><name><surname>Eugster</surname> <given-names>A</given-names></name><name><surname>Tsuji</surname> <given-names>N</given-names></name><name><surname>Morrissey</surname> <given-names>ER</given-names></name><name><surname>Brand</surname> <given-names>M</given-names></name><name><surname>Ninov</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Different developmental histories of beta-cells generate functional and proliferative heterogeneity during islet growth</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>664</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00461-3</pub-id><pub-id pub-id-type="pmid">28939870</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speckmann</surname> <given-names>T</given-names></name><name><surname>Sabatini</surname> <given-names>PV</given-names></name><name><surname>Nian</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>RG</given-names></name><name><surname>Lynn</surname> <given-names>FC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Npas4 transcription factor expression is regulated by calcium signaling pathways and prevents Tacrolimus-induced cytotoxicity in pancreatic beta cells</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>2682</fpage><lpage>2695</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.704098</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name><name><surname>Detrich</surname> <given-names>HW</given-names></name><name><surname>Zon</surname> <given-names>LI</given-names></name><name><surname>Fishman</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages</article-title><source>Development</source><volume>121</volume><fpage>3141</fpage><lpage>3150</lpage><pub-id pub-id-type="doi">10.1242/dev.121.10.3141</pub-id><pub-id pub-id-type="pmid">7588049</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumanas</surname> <given-names>S</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ets1-related protein is a key regulator of vasculogenesis in zebrafish</article-title><source>PLOS Biology</source><volume>4</volume><elocation-id>e10</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0040010</pub-id><pub-id pub-id-type="pmid">16336046</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumazaki</surname> <given-names>R</given-names></name><name><surname>Shiojiri</surname> <given-names>N</given-names></name><name><surname>Isoyama</surname> <given-names>S</given-names></name><name><surname>Masu</surname> <given-names>M</given-names></name><name><surname>Keino-Masu</surname> <given-names>K</given-names></name><name><surname>Osawa</surname> <given-names>M</given-names></name><name><surname>Nakauchi</surname> <given-names>H</given-names></name><name><surname>Kageyama</surname> <given-names>R</given-names></name><name><surname>Matsui</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Conversion of biliary system to pancreatic tissue in Hes1-deficient mice</article-title><source>Nature Genetics</source><volume>36</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1038/ng1273</pub-id><pub-id pub-id-type="pmid">14702043</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarifeño-Saldivia</surname> <given-names>E</given-names></name><name><surname>Lavergne</surname> <given-names>A</given-names></name><name><surname>Bernard</surname> <given-names>A</given-names></name><name><surname>Padamata</surname> <given-names>K</given-names></name><name><surname>Bergemann</surname> <given-names>D</given-names></name><name><surname>Voz</surname> <given-names>ML</given-names></name><name><surname>Manfroid</surname> <given-names>I</given-names></name><name><surname>Peers</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptome analysis of pancreatic cells across distant species highlights novel important regulator genes</article-title><source>BMC Biology</source><volume>15</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-017-0362-x</pub-id><pub-id pub-id-type="pmid">28327131</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id><pub-id pub-id-type="pmid">18193022</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname> <given-names>N</given-names></name><name><surname>Ninov</surname> <given-names>N</given-names></name><name><surname>Delawary</surname> <given-names>M</given-names></name><name><surname>Osman</surname> <given-names>S</given-names></name><name><surname>Roh</surname> <given-names>AS</given-names></name><name><surname>Gut</surname> <given-names>P</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Whole organism high content screening identifies stimulators of pancreatic beta-cell proliferation</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e104112</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0104112</pub-id><pub-id pub-id-type="pmid">25117518</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldman</surname> <given-names>MB</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Etsrp/Etv2 is directly regulated by <italic>Foxc1a/b</italic> in the zebrafish angioblast</article-title><source>Circulation Research</source><volume>110</volume><fpage>220</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.251298</pub-id><pub-id pub-id-type="pmid">22135404</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vierbuchen</surname> <given-names>T</given-names></name><name><surname>Ostermeier</surname> <given-names>A</given-names></name><name><surname>Pang</surname> <given-names>ZP</given-names></name><name><surname>Kokubu</surname> <given-names>Y</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name><name><surname>Wernig</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Direct conversion of fibroblasts to functional neurons by defined factors</article-title><source>Nature</source><volume>463</volume><fpage>1035</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1038/nature08797</pub-id><pub-id pub-id-type="pmid">20107439</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Waddington</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="1957">1957</year><source>The Strategy of the Genes; a Discussion of Some Aspects of Theoretical Biology</source><publisher-name>Allen &amp; Unwin</publisher-name></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>YJ</given-names></name><name><surname>Park</surname> <given-names>JT</given-names></name><name><surname>Parsons</surname> <given-names>MJ</given-names></name><name><surname>Leach</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fate mapping of <italic>ptf1a</italic>-expressing cells during pancreatic organogenesis and regeneration in zebrafish</article-title><source>Developmental Dynamics</source><volume>244</volume><fpage>724</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1002/dvdy.24271</pub-id><pub-id pub-id-type="pmid">25773748</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Wierson</surname> <given-names>WA</given-names></name><name><surname>Welker</surname> <given-names>JM</given-names></name><name><surname>Almeida</surname> <given-names>MP</given-names></name><name><surname>Mann</surname> <given-names>CM</given-names></name><name><surname>Webster</surname> <given-names>DA</given-names></name><name><surname>Torrie</surname> <given-names>ME</given-names></name><name><surname>Weiss</surname> <given-names>TJ</given-names></name><name><surname>Vollbrecht</surname> <given-names>MK</given-names></name><name><surname>Lan</surname> <given-names>M</given-names></name><name><surname>McKeighan</surname> <given-names>KC</given-names></name><name><surname>Levey</surname> <given-names>J</given-names></name><name><surname>Ming</surname> <given-names>Z</given-names></name><name><surname>Wehmeier</surname> <given-names>A</given-names></name><name><surname>Mikelson</surname> <given-names>CS</given-names></name><name><surname>Haltom</surname> <given-names>JA</given-names></name><name><surname>Kwan</surname> <given-names>KM</given-names></name><name><surname>Chien</surname> <given-names>C-B</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Webber</surname> <given-names>BR</given-names></name><name><surname>Moriarity</surname> <given-names>B</given-names></name><name><surname>Solin</surname> <given-names>SL</given-names></name><name><surname>Carlson</surname> <given-names>DF</given-names></name><name><surname>Dobbs</surname> <given-names>DL</given-names></name><name><surname>McGrail</surname> <given-names>M</given-names></name><name><surname>Essner</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>GeneWeld: a method for efficient targeted integration directed by short homology</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/431627</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>S</given-names></name><name><surname>Russ</surname> <given-names>HA</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Ma</surname> <given-names>T</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name><name><surname>Tang</surname> <given-names>S</given-names></name><name><surname>Hebrok</surname> <given-names>M</given-names></name><name><surname>Ding</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Human pancreatic beta-like cells converted from fibroblasts</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10080</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10080</pub-id><pub-id pub-id-type="pmid">26733021</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65758.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Ober</surname><given-names>Elke</given-names></name><role>Reviewing Editor</role><aff><institution>University of Copenhagen</institution><country>Denmark</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ober</surname><given-names>Elke</given-names> </name><role>Reviewer</role><aff><institution>University of Copenhagen</institution><country>Denmark</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Gouon-Evans</surname><given-names>Valerie</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/10.1101/2021.02.01.429189">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.02.01.429189v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This is an elegant study demonstrating the emergence of mesoderm-derived β-like cells following β-cell ablation in the context of compromised endothelial/myeloid lineage specification. These findings will be of interest to scientists in the areas of regeneration and reprogramming, as they reveal a previously unknown degree of germ layer plasticity in the embryo. In the long term the study has potential impact in the diabetes field, as it reveals a potentially novel path for redirecting somatic cells into insulin-producing cells in an in vivo context.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Regenerating insulin-producing β-cells ectopically from a mesodermal origin in the absence of endothelial specification&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Elke Ober as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Marianne Bronner as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Valerie Gouon-Evans (Reviewer #3).</p><p>Essential Revisions:</p><p>1) Improve characterization of β-cell differentiation derived from mesoderm-endoderm conversion. The manuscript provides strong evidence that mesoderm-derived ectopic β-cells generated after β-cell ablation express insulin, nevertheless the characterization is too superficial to conclude there is a full conversion to endoderm. Indeed, the authors describe that in contrast to pancreatic β cells, most ectopic β-cells lack the pan-endocrine marker neurod1 and the key β cell gene pdx1 (Figure 2 and Figure 2-S1), suggesting these cells clearly differ from bona fide β-cells. In addition, analysis of endodermal or mesodermal markers is lacking, making it difficult to understand the exact nature of these ectopic cells. Therefore, a more comprehensive analysis of relevant key endodermal and mesodermal genes is required to better describe the β-cell state of these ectopic cells and determine the degree of germ layer conversion.</p><p>2) Address the competence of mesodermal cells converting into β-like cells in larvae with impaired npas4l and etv2 function. The manuscript does not sufficiently discuss the identity of the mesodermal cell population that in the absence of endothelial specification (npas4l-/- and etv2 MO) can adopt a β-cell like identity following β-cell ablation. Specifically, the following points should be discussed:</p><p>i) why are they competent to differentiate into insulin+ cells in response to β cell ablation? The authors could make use of the recent studies cited in the present paper and of the respective transcriptomic data (Marass, Development, 2019; Chestnut, Nat Commun, 2020).</p><p>ii) is there a temporal window of competence for extra β-cells to form in the mesenchyme? Is this restricted to continued development? Could this be tested in adults?</p><p>iii) is the competence to form extra β-cells restricted to the vicinity of the pancreas? If so, which signals control this, given that normally endothelial cells form along the anteroposterior axis, however do not adopt a β-cell like fate in npas4l mutants or etv2morphants?</p><p>iv) what is the possible mechanism of this specification?</p><p>3) The mesodermal lineage tracing experiments, which are a central part of the study, require additional support. Please define efficiency and specificity of the tracing approach by showing mCherry+ mesodermal cells co-stained with a mesodermal marker (e.g. drl, or alternative mesodermal gene expressed at the stages of ectopic β-cell analysis) in additional areas of the larvae. This should include control embryos for both mesodermal Cre-drivers (drl:CreERT2 and etv2:iCre) to show their exclusive mesoderm expression.</p><p>4) The etv2 knockdown requires further validation. Elongated cells resembling endothelial cells marked with the etv2 lineage mapping present in etv2 morphants suggests that endothelial cells still form. Related to this, using only a single etv2 and single standard control morpholino is surprising given the known problems with this approach. Please validate the use of the etv2 morpholino knockdowns according to Stainier et al., 2017. Moreover, endothelial cell identity of above cells should be tested.</p><p>In case these results are confirmed, it would suggest that the mechanism of ectopic β-cells emergence in etv2 morphants and npas4l mutants does not depend on the absence of endothelial cells per se. It may also suggest that the mechanism of ectopic β cells formation in etv2 morphants vs npas4l mutant is different. This should be discussed as the role of vasculogenesis and vascularization for β cell regeneration was the first motivation for this study, as introduced in the result section.</p><p>5) Clarification of assessment criteria for different insulin+ cell populations and their localization to the principle islet or ectopic tissues.</p><p>The regenerated β cells seem to be broadly distributed and not always seem to form a distinct islet, but are nevertheless assigned to the pancreatic domain (see Figure 1E). To clarify how the pancreatic and the ectopic domains have been discriminated in these experiments, please provide additional details how both populations have been identified.</p><p>Moreover, lineage labelled Ins+Cherry+ cells from the mesoderm are also found within the pancreas; for instance a substantial fraction of regenerated β-cells defined as pancreatic seems to derive from etv2+ mesodermal cells in etv2 morphants (Figure 4B). This raises the question of the identity and of these &quot;pancreatic&quot; cells and where they arise from, and requires additional characterization and explanation.</p><p>The β-like cells appear to come from the lateral plate mesoderm (supplement figure4), please specify at least once in the text for clarity of lineage relationship.</p><p>6) The interpretation of glucose measurements needs to be revisited, given the relevance of measuring free tissue glucose as proxy for the effect of insulin released by ectopic cells in npas4l mutants is questionable. npas4l mutants have no capillaries nor blood to vehicle the hormone to target tissues in mutants. It is likely that the glucose values obtained for the mutants are not the result of insulin action, and hence may not provide a reliable estimation of ectopic cell function. This would be more convincing, for example, if a transient increase is observed after ablation before normalization. If this is the case, the authors should experimentally test whether increasing glucose levels in non-ablated npas4l mutants would trigger a similar formation of ectopic β-cells.</p><p>Therefore, please provide further support or adjust and discuss the conclusions.</p><p>7) The significance of the conversion of other endocrine cell types, specifically somatostatin+ cells, from mesoderm in npas4l mutants needs to be clarified. The increase in the number of ectopic sst2 cells after δ-cell ablation presented in Figure 1 Supplement 2F is very mild and in addition ectopic sst2 cell seem to frequently form in controls outside the pancreas. Please clarify and discuss general implications for the competence of the mesenchyme for the appearance of endocrine cells outside the pancreas, as in its current form, this result is more confusing than supporting the other results.</p><p>Has the normal distribution of data points in Figure 1 supplement 2F been tested for control and npas4l datasets?</p><p>8) A number of clarifications and additions to the text and figures are required:</p><p>- The title requires attention, it seems grammatically incorrect, e.g. lacking a verb.</p><p>- Figure 2 indicates that the extra b-cell phenotype is not fully penetrant, please include this in the manuscript.</p><p>- Clarify and specify in all figure legends what the red staining represents, e.g. DsRed fluorescence driven by the insulin promoter or immunofluorescence staining for insulin?</p><p>- Figure 1, supplement 1: Please delineate the pancreas in panels C and D to reveal the ectopic sites of emerging β-like cells.</p><p>- p-Cadherin: please spell out PanCadherin in the figures to avoid confusion with a phosphorylated Cadherin form.</p><p>- Please include short explanation for iCre in the text or methods.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Insulin-producing β-cells regenerate ectopically from a mesodermal origin under the perturbation of hemato-endothelial specification&quot; for further consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Valerie Gouon-Evans (Reviewer #3).</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below.</p><p>The manuscript does not require any further experimental data, nevertheless, we ask you to address some important additions to the text, as suggested by the reviewers. Including the following changes will add essential information and will help to make your work more accessible to the reader:</p><p>– mention once in the manuscript the previous name of etsrp (etv2) for the sake of visibility and clarity.</p><p>– precise when 4OHT was applied in the control experiment shown in Figure 4 – Supplement figure 3 (drl:CRE-ERT in the heart).</p><p>– include the characterization of specificity and efficiency of the lineage tracing etsrp:Cre in the manuscript as described in the rebuttal letter (response to point 3).</p><p>– summarize lines 289-294 (Discussion) to simply suggest that the possibly versatile mutant mesodermal cells could be the origin of the ectopic β cells.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The revised version of this manuscript and the rebuttal letter carefully address all the concerns and the remarks raised by the first version:</p><p>The title and the general conclusions have been adequately adapted so that they more fairly correspond to the observed phenomenon of ectopic pancreatic β cell formation in the mesoderm. The manuscript now presents some interesting discussion about the plasticity of mesodermal cells.</p><p>Importantly, the authors have better characterized their lineage tracing tools. Also, they include a third tool, a GAL4-VP16 knockin in the npas4l locus to be used with UAS:CRE;ubb:switch. Together, these three lineage tracing systems convincingly support the conclusion that many ectopic pancreatic cells are from mesodermal origin. It is to note, however, that this third tool is only minimally described as it is said it will be presented in another paper submitted by colleagues.</p><p>The study now provides in vivo Calcium imaging of ectopic (compared to pancreatic) β cells, which is an accurate way to assess the capacity of these cells to respond to glucose. This also adds to the asked characterization of the ectopic β cells.</p><p>The use of a secondo morpholino against etv2/etsrp is now presented, as well as the synergy between both (with respect to the number of ectopic β cells that form during regeneration). This analysis complies with previously published guidelines for MO.</p><p>In addition, the figures and Methods provide clarification about the way cells have been assigned a pancreatic or ectopic localization.</p><p>Source data for the quantifications shown in each figure are provided.</p><p>Overall, the revised version is greatly improved.</p><p>Additional recommendations:</p><p>– mention once in the manuscript the previous name of etsrp (etv2) for the sake of visibility and clarity.</p><p>– precise when 4OHT was applied in the control experiment shown in Figure 4 – Supplement figure 3 (drl:CRE-ERT in the heart).</p><p>– summarize lines 289-294 (Discussion) to simply suggest that the possibly versatile mutant mesodermal cells could be the origin of the ectopic β cells.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Overall, the revisions are satisfactory and have greatly improved the manuscript.</p><p>Point #1: I agree that the new data using the npas4lPt(+36-npas4l-p2a-Gal4-VP16)bns423 fish crossed either with Tg(UAS:Cre);Tg(ubi:Switch) or Tg(UAS:EGFP) fish provide additional evidence for the mesodermal origin of the de novo β cells that are characterized with loss of the mesodermal marker expression npas4l.</p><p>Additional discussion addresses well point #2.</p><p>Point #3: Please include the characterization of specificity and efficiency of the lineage tracing etsrp:Cre in the manuscript as described in the rebuttal letter.</p><p>Point #4: MO2 data support well the previous MO1 data.</p><p>Point #5 is well addressed.</p><p>Point #6: Evaluation of calcium signaling in the ectopic β-cells by live imaging in vivo is useful to examine cell maturation.</p><p>Point #7: Removal of data related to somatostatin+ cells is appropriate.</p><p>Point #8: Well addressed.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65758.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1) Improve characterization of β-cell differentiation derived from mesoderm-endoderm conversion. The manuscript provides strong evidence that mesoderm-derived ectopic β-cells generated after β-cell ablation express insulin, nevertheless the characterization is too superficial to conclude there is a full conversion to endoderm. Indeed, the authors describe that in contrast to pancreatic β cells, most ectopic β-cells lack the pan-endocrine marker neurod1 and the key β cell gene pdx1 (Figure 2 and Figure 2-S1), suggesting these cells clearly differ from bona fide β-cells. In addition, analysis of endodermal or mesodermal markers is lacking, making it difficult to understand the exact nature of these ectopic cells. Therefore, a more comprehensive analysis of relevant key endodermal and mesodermal genes is required to better describe the β-cell state of these ectopic cells and determine the degree of germ layer conversion.</p></disp-quote><p>We agree with the reviewers that the ectopic β-cells are not identical to the <italic>bona fide</italic> β-cells and more characterization of the ectopic β-cells would be necessary to fully understand their cellular state. Therefore in the revision we have included a new zebrafish tool <italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup></italic>, which not only allows us to trace the mesodermal <italic>npas4l</italic>-positive lineage of the endothelial and hematopoietic progenitors after crossing into <italic>Tg(UAS:Cre);Tg(ubi:Switch)</italic>, but also reports the expression of this important regulator of the mesodermal cell fate after crossing into <italic>Tg(UAS:EGFP)</italic>. The details and characterization of this new fish line are reported in another manuscript by K.M. and D.Y.R.S (submitted).</p><p>In the new Figure 5, we have shown that some of the ectopic β-cells could be traced back to the mesodermal <italic>npas4l</italic> lineage while none of the ectopic β-cells were still actively expressing <italic>npas4l</italic> as reported by EGFP at 3 dpf. This indicates that at least some of these ectopic β-cells from the <italic>npas4l</italic> lineage had lost this mesodermal marker and begun to express insulin and other endodermal endocrine markers (Figure 2).</p><p>In addition, we examined the expression patterns of some early mesodermal or endodermal markers (<italic>foxa2</italic>, <italic>gsc</italic> and <italic>mixl1</italic>) and we did not see any significant differences in the <italic>npas4l</italic> mutants (Figure 4—figure supplement 1), indicating that <italic>npas4l</italic> mutation did not significantly perturb the early formation of mesoderm and endoderm.</p><disp-quote content-type="editor-comment"><p>2) Address the competence of mesodermal cells converting into β-like cells in larvae with impaired npas4l and etv2 function. The manuscript does not sufficiently discuss the identity of the mesodermal cell population that in the absence of endothelial specification (npas4l-/- and etv2 MO) can adopt a β-cell like identity following β-cell ablation. Specifically, the following points should be discussed:</p><p>i) why are they competent to differentiate into insulin+ cells in response to β cell ablation? The authors could make use of the recent studies cited in the present paper and of the respective transcriptomic data (Marass, Development, 2019; Chestnut, Nat Commun, 2020).</p></disp-quote><p>We thank the reviewers’ suggestion of making use of these two studies to discuss the competence of the mesodermal cell population differentiating into ectopic β-cells. We have now substantially expanded this discussion point and referred to the suggested references (Lines 277-305).</p><disp-quote content-type="editor-comment"><p>ii) is there a temporal window of competence for extra β-cells to form in the mesenchyme? Is this restricted to continued development? Could this be tested in adults?</p></disp-quote><p>The formation of ectopic β-cells, unfortunately, cannot be tested in adult <italic>cloche</italic> mutants because their health conditions start to deteriorate from 3 days post-fertilisation (dpf) and they die at 4-5 dpf. Therefore, they can never reach the adult stage. We analysed the cloche mutants at 3 dpf in the current manuscript but we also tried to examine them at 4 dpf, but there were worsened health conditions of the <italic>cloche</italic> mutants in general that prohibited a meaningful analysis. In addition, the first insulin-expressing β-cell does not show up before 15 hr post-fertilisation (hpf). Thus, there is not much room for us to move the ablation procedure earlier than what we did in the current manuscript (with a start at ~24 hpf).</p><disp-quote content-type="editor-comment"><p>iii) is the competence to form extra β-cells restricted to the vicinity of the pancreas? If so, which signals control this, given that normally endothelial cells form along the anteroposterior axis, however do not adopt a β-cell like fate in npas4l mutants or etv2morphants?</p></disp-quote><p>We believe that the vicinity of the pancreas could be an important factor for the competence of some mesodermal cells to form ectopic β-cells. However, this is difficult to prove before we precisely know which population of mesodermal cells can differentiate across the germ layers to endodermal β-cells. If we had knowledge of this, we could have isolated those cells and transplanted them into different positions to study the importance of the vicinity of the pancreas.</p><p>In addition, our new lineage-tracing data has shown that some of the ectopic β-cells could be traced back to the <italic>npas4l</italic> lineage (Figure 5), suggesting that the <italic>npas4l</italic>-expressing lateral plate mesoderm not far from the pancreas (Figure 4—figure supplement 1) could be the source of the ectopic β-cells. We have added this point to the newly expanded discussion (Line 296).</p><disp-quote content-type="editor-comment"><p>iv) what is the possible mechanism of this specification?</p></disp-quote><p>As supported by the transcriptomic data (Marass, Development, 2019; Chestnut, Nat Commun, 2020), we propose that a small population of cells from the lateral plate mesoderm have lost their mesodermal cell fate in <italic>npas4l</italic> mutants or <italic>etsrp</italic> (<italic>etv2</italic>) morphants, which maintains the plasticity of these cells and allows them to differentiate into ectopic β-cells during β-cell regeneration. We have discussed this possible mechanism in the expanded discussion (Lines 277-305), although the detailed molecular mechanisms remain elusive.</p><disp-quote content-type="editor-comment"><p>3) The mesodermal lineage tracing experiments, which are a central part of the study, require additional support. Please define efficiency and specificity of the tracing approach by showing mCherry+ mesodermal cells co-stained with a mesodermal marker (e.g. drl, or alternative mesodermal gene expressed at the stages of ectopic β-cell analysis) in additional areas of the larvae. This should include control embryos for both mesodermal Cre-drivers (drl:CreERT2 and etv2:iCre) to show their exclusive mesoderm expression.</p></disp-quote><p>We thank the reviewers for pointing out the importance of characterizing the Cre-drivers for lineage-tracing, especially with regards to the <italic>etsrp:Cre</italic> (which we previously called <italic>etv2:iCre</italic>), which has been newly made for this manuscript. We understand the significance of having an efficient and specific lineage-tracing approach, while we also realize that no approach is absolutely perfect. Therefore, in this revised manuscript, we have included yet another lineage tracer <italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup>;UAS:Cre;ubi:Switch.</italic> Together with the other two mesodermal lineage tracers <italic>drl:CreER<sup>T2</sup>;ubi:Switch</italic> and <italic>etsrp:Cre;ubi:Switch</italic>, we hope these three lineage tracers would complement each other to provide convincing evidence to show that the ectopic β-cells came from an mesodermal origin.</p><p>The Cre-driver <italic>drl:CreER<sup>T2</sup> </italic>has been extensively characterized by Mosimann and others [Nat Commun 6, 8146 (2015)] and it can genetically trace the lateral plate mesoderm descendants including cardiac mesoderm, pectoral find mesoderm, red blood cells, kidney, vasculature and trunk muscle cells. In the revised manuscript, we have added images to show that this tracer could respond to tamoxifen induction and genetically trace cardiac cells (Figure 4—figure supplement 3). Moreover, we have constructed <italic>etsrp:Cre</italic> based on the promoter of <italic>-2.3estrp:GFP</italic>, which has been demonstrated to closely recapitulate the endogenous <italic>etsrp</italic> expression in lateral plate mesoderm and vasculatures by Veldman and Lin [Circ Res 110, 220-9 (2012)]. We have shown that <italic>etsrp:Cre</italic> can trace over 80% of <italic>kdrl:GFP</italic>-expressing intersegmental vessels (Figure 6—figure supplement 1). Furthermore, the new fish model <italic>npas4l<sup>Pt(+36-npas4l-p2a-Gal4-VP16)bns423</sup></italic> has been characterised in another manuscript by K.M. and D.Y.R.S (submitted).</p><disp-quote content-type="editor-comment"><p>4) The etv2 knockdown requires further validation. Elongated cells resembling endothelial cells marked with the etv2 lineage mapping present in etv2 morphants suggests that endothelial cells still form. Related to this, using only a single etv2 and single standard control morpholino is surprising given the known problems with this approach. Please validate the use of the etv2 morpholino knockdowns according to Stainier et al., 2017. Moreover, endothelial cell identity of above cells should be tested.</p><p>In case these results are confirmed, it would suggest that the mechanism of ectopic β-cells emergence in etv2 morphants and npas4l mutants does not depend on the absence of endothelial cells per se. It may also suggest that the mechanism of ectopic β cells formation in etv2 morphants vs npas4l mutant is different. This should be discussed as the role of vasculogenesis and vascularization for β cell regeneration was the first motivation for this study, as introduced in the result section.</p></disp-quote><p>We agree with the reviewers that the formation of ectopic β-cells does not require the complete absence of endothelial cells and it is common that the phenotypes in morphants does not have complete penetrance. Sumanas and Lin have also shown the dose-dependent and incomplete effects of <italic>etsrp</italic> (<italic>etv2</italic>) morpholinos [PLoS Biol 4(1):e10 (2006)]. Therefore, we have changed the title of the manuscript to “Insulin-producing β-cells regenerate ectopically from a mesodermal origin under the perturbation of hemato-endothelial specification”.</p><p>In the revision, we have added another widely used <italic>etsrp</italic> morpholino (MO1) in addition to the MO2 included in the original submission. Both MO1 and MO2 could induce the formation of ectopic β-cells independently compared to the random control morpholino (instead of the standard control). Importantly, co-injecting lower doses of MO1 and MO2 could exert a synergistic effect on ectopic β-cell formation (Figure 4—figure supplement 4), suggesting that both morpholinos are specifically targeting <italic>etsrp</italic> (in line with the suggestions in Stainier et al., 2017). Interestingly, similar to the higher effectiveness of MO2 on inducing the complete loss of circulation reported by Sumanas and Lin [PLoS Biol 4(1):e10 (2006)], MO2 also tended to be more potent than MO1 in inducing ectopic β-cell formation. We have also tried to block the ectopic β-cell formation by co-injecting <italic>etsrp</italic> mRNA with MO2. However, <italic>etsrp</italic> mRNA did not significantly stop the ectopic β-cell formation, which might be due to mRNA degradation.</p><p>It is true that we cannot absolutely rule out the possibility that the mechanisms of ectopic β-cell formation in <italic>npas4l</italic> mutants and <italic>etsrp</italic> morphants could be different. Therefore, we have added a statement in the discussion part (Lines 302-305). However, the lack of vasculatures is unlikely the major driving force for ectopic β-cell formation because we did not observe the same phenotype in zebrafish embryos treated with chemicals that inhibit angiogenesis.</p><disp-quote content-type="editor-comment"><p>5) Clarification of assessment criteria for different insulin+ cell populations and their localization to the principle islet or ectopic tissues.</p><p>The regenerated β cells seem to be broadly distributed and not always seem to form a distinct islet, but are nevertheless assigned to the pancreatic domain (see Figure 1E). To clarify how the pancreatic and the ectopic domains have been discriminated in these experiments, please provide additional details how both populations have been identified.</p><p>Moreover, lineage labelled Ins+Cherry+ cells from the mesoderm are also found within the pancreas; for instance a substantial fraction of regenerated β-cells defined as pancreatic seems to derive from etv2+ mesodermal cells in etv2 morphants (Figure 4B). This raises the question of the identity and of these &quot;pancreatic&quot; cells and where they arise from, and requires additional characterization and explanation.</p><p>The β-like cells appear to come from the lateral plate mesoderm (supplement figure4), please specify at least once in the text for clarity of lineage relationship.</p></disp-quote><p>We thank the reviewers for expressing concerns about the criteria for defining the pancreatic and ectopic β-cells. Now we have clarified in the Methods part how we classified these two domains during the various analyses (Lines 443-447). It was completely based on the location of the β-cells—i.e., whether they were in the pancreas or not, while the region of the pancreas was defined by the signals of <italic>ptf1a:EGFP</italic>, DAPI or pan-cadherin staining.</p><p>We agree that the ectopic β-cells were not very clearly illustrated in the previous Figure 1E when we tried to keep the dashed rectangle intact. In this revised version, we have modified the way of illustration and delineated the whole pancreatic domains to make things clearer (Figure 1D and E). Newly regenerated β-cells usually appear more dispersed than those under basal development without ablation and it often takes a few more days of recovery before they cluster together.</p><p>Without the inducible ER<sup>T2</sup> temporal control, some low- or miss-expression of <italic>etsrp:Cre</italic> (<italic>etv2:iCre</italic>) in early progenitors from mesendoderm might be sufficient enough to trigger the Cre-recombination <italic>ubi:Switch</italic> and genetically traced a few descendants of mesendoderm, including the endodermal pancreatic islet. Therefore, in this revised manuscript, we have included three different lineage-tracing models to complement each other to minimise the influence of any confounding effect.</p><p>In addition, we have added the point of the lateral plate mesoderm being a potential origin of the ectopic β-cells in the expanded discussion (Lines 277-305).</p><disp-quote content-type="editor-comment"><p>6) The interpretation of glucose measurements needs to be revisited, given the relevance of measuring free tissue glucose as proxy for the effect of insulin released by ectopic cells in npas4l mutants is questionable. npas4l mutants have no capillaries nor blood to vehicle the hormone to target tissues in mutants. It is likely that the glucose values obtained for the mutants are not the result of insulin action, and hence may not provide a reliable estimation of ectopic cell function. This would be more convincing, for example, if a transient increase is observed after ablation before normalization. If this is the case, the authors should experimentally test whether increasing glucose levels in non-ablated npas4l mutants would trigger a similar formation of ectopic β-cells.</p><p>Therefore, please provide further support or adjust and discuss the conclusions.</p></disp-quote><p>We thank the reviewers for pointing out the potential problems of the glucose experiment. Hence, we tried to collect the zebrafish samples earlier at different time points to see if there was a transient increase in free glucose levels in the <italic>npas4l</italic> mutants after β-cell ablation. However, we only sometimes saw a mild but insignificant increase in the glucose levels, suggesting that there was likely no severely elevated glucose level for the ectopic β-cells to tackle with and increased glucose level was not a crucial factor for the formation of the ectopic β-cells.</p><p>Instead, during the revision of the manuscript, we have examined the calcium signalling in the ectopic β-cells by live imaging in vivo to see how mature they are as secretory cells. Similar to some of the pancreatic β-cells, a portion of ectopic β-cells also displayed certain basal calcium activity at the baseline and responded to glucose treatments with calcium oscillations in the <italic>npas4l</italic> mutants (Figure 3), suggesting that some of the ectopic β-cells are glucose-responsive secretory cells.</p><disp-quote content-type="editor-comment"><p>7) The significance of the conversion of other endocrine cell types, specifically somatostatin+ cells, from mesoderm in npas4l mutants needs to be clarified. The increase in the number of ectopic sst2 cells after δ-cell ablation presented in Figure 1 Supplement 2F is very mild and in addition ectopic sst2 cell seem to frequently form in controls outside the pancreas. Please clarify and discuss general implications for the competence of the mesenchyme for the appearance of endocrine cells outside the pancreas, as in its current form, this result is more confusing than supporting the other results.</p><p>Has the normal distribution of data points in Figure 1 supplement 2F been tested for control and npas4l datasets?</p></disp-quote><p>We agree with the reviewers that the data of somatostatin+ cells may not be very helpful. Therefore, we have removed this part of the data from the revised manuscript.</p><disp-quote content-type="editor-comment"><p>8) A number of clarifications and additions to the text and figures are required:</p></disp-quote><p>– <italic>The title requires attention, it seems grammatically incorrect, e.g. lacking a verb.</italic></p><p>We have changed the title to “Insulin-producing β-cells regenerate ectopically from a mesodermal origin under the perturbation of hemato-endothelial specification”.</p><p>– <italic>Figure 2 indicates that the extra b-cell phenotype is not fully penetrant, please include this in the manuscript.</italic></p><p>The quantifications of Figure 2 are not optimal for describing the penetrance of the phenotype because an individual with all the Ins+ cells carrying a marker (e.g. Ins+Isl1+ cells) would result in zero Ins+ only cells in the same individual but it does not mean the individual carries no ectopic Ins+ cells. Figure 1 is more suitable for showing the penetrance with the total ectopic β-cell number. We did not get 100% penetrance in every single experiment (although the penetrance of ectopic β-cells is very high), which could be dependent on different β-cell reporters/immunostaining, slight variations of developmental stages of individuals, or mild variations of the β-cell ablation.</p><p>– <italic>Clarify and specify in all figure legends what the red staining represents, e.g. DsRed fluorescence driven by the insulin promoter or immunofluorescence staining for insulin?</italic></p><p>We thank the reviewers’ suggestion and we have clarified the red fluorescence in the figure legends in the revised manuscript.</p><p>– <italic>Figure 1, supplement 1: Please delineate the pancreas in panels C and D to reveal the ectopic sites of emerging β-like cells.</italic></p><p>We have added white lines to delineate the pancreas in Figure 1—figure supplement 1.</p><p>– <italic>p-Cadherin: please spell out PanCadherin in the figures to avoid confusion with a phosphorylated Cadherin form.</italic></p><p>We have changed the term p-Cadherin to pan-Cadherin.</p><p>– <italic>Please include short explanation for iCre in the text or methods.</italic></p><p>The iCre used in the study is improved Cre-recombinase. We have abbreviated iCre as Cre to avoid confusion and added a short description of it in the methods (Lines 364-366).</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The manuscript does not require any further experimental data, nevertheless, we ask you to address some important additions to the text, as suggested by the reviewers. Including the following changes will add essential information and will help to make your work more accessible to the reader:</p><p>– mention once in the manuscript the previous name of etsrp (etv2) for the sake of visibility and clarity.</p></disp-quote><p>Now we have mentioned the previous name of <italic>etsrp</italic> in the introduction (line 78 in the word document / line 79 after conversion to the pdf document).</p><disp-quote content-type="editor-comment"><p>– precise when 4OHT was applied in the control experiment shown in Figure 4 – Supplement figure 3 (drl:CRE-ERT in the heart).</p></disp-quote><p>The information has been added to the figure legend (line 946 in word/961 in pdf).</p><disp-quote content-type="editor-comment"><p>– include the characterization of specificity and efficiency of the lineage tracing etsrp:Cre in the manuscript as described in the rebuttal letter (response to point 3).</p></disp-quote><p>The description of the characterisation has been further expanded (line 229-231 in word/234-236 in pdf).</p><disp-quote content-type="editor-comment"><p>– summarize lines 289-294 (Discussion) to simply suggest that the possibly versatile mutant mesodermal cells could be the origin of the ectopic β cells.</p></disp-quote><p>Text changes have been made to make a simpler summary (line 291-293/298-300 in pdf).</p></body></sub-article></article>